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INTRODUCTION 
Osteogenesis imperfecta (OI) is a heterogeneous genetic 
disease which has been characterized by extremely fragile 
bones and other connective tissue abnormalities (Sillence et 
al., 1979a, 1979b; Prockop, 1984). Molecular defects in the 
Type I collagen genes which affect the synthesis and/ or 
structure of the collagen protein are involved in many cases 
of OI (Prockop et al., 1989; Byers, 1989; Cole et al., 1989). 
Most of these mutations alter the repeated Gly-X-Y amino acid 
sequence in the triple helical domain, leading to the 
formation of an unstable helix which compromises the tensile 
strength of mature collagen fibrils (Pope et al., 1989). 
The severity of the OI symptoms vary considerably 
between individuals and no two cases have been found to have 
exactly the same molecular defect. In cases where individuals 
have similar mutations their phenotypes can vary greatly 
(Pope et al., 1985). Furthermore, there are instances where 
multiple asymptomatic members of a family carry the same 
defect as the affected individual (Superti-Furga et al., 
1989; Sykes et al., 1990). In some cases of OI, particularly 
the progressively deforming moderately severe form of the 
disease, or OI Type III, no apparent Type I collagen defects 
have been found (Byers et al., 1987; Aitchison et al., 
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1988). Thus, there are clearly additional genes involved in 
contributing to the OI phenotype other than the Type I 
collagen genes. 
Previous studies have shown that a pro-a2(I) collagen 
complementary DNA (cDNA) probe detects two previously-
undescribed sites in collagen-like gene (s) other than the 
already characterized f ibrillar collagen genes (Doering et 
al., 1990). Deletions at the two sites are found to occur 
much more frequently in OI Type III patients than in normal 
individuals. At both sites the deletions occur in a 
spontaneous fashion and are of heterogeneous size (Doering et 
al., 1987). Site 1 is detected in normal individuals as a 7.4 
kb HindIII restriction fragment which completely contains a 
3.0 kb PstI fragment. Site 2 is detected as a 4.6 kb HindIII 
fragment in normal individuals which overlaps with a 5.2 kb 
PstI fragment. Site 2 has recently been localized to 
chromosome 17 (Cammarata et al., 1991). 
This thesis describes the isolation and 
characterization of Site 2, specifically the 4.6 kb HindIII 
fragment. The cloning, mapping and sequencing of its triple 
helical coding regions are described. Sequence comparisons to 
known collagen genes, as well as other non-collagenous genes, 
are made in an effort to further characterize this gene and 
gain insight to its function. This sequence information will 
help to identify the structure of the putative collagen-like 
protein which the sequence encodes and thus suggest how 
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abnormalities in this protein could contribute to the OI 
phenotype. 
LITERATURE REVIEW 
OI and Type I Collagen 
Osteogenesis imperf ecta is one of the most common 
connective tissue disorders and occurs in approximately 1 in 
5,000 to 10,000 individuals (Byers and Steiner, 1992). In 
addition to fragile bones which fracture under minimal stress, 
other symptoms occur to a varying degree, including 
dentinogenesis imperfecta, thin skin, joint hypermobility, 
blue sclerae and hearing impairment (Sillence, 1988; Byers, 
1989). All of the affected tissues are rich in Type I collagen 
and many, but not all, OI cases are associated with defects 
in one of the two Type I collagen genes, COLlAl or COL1A2 
(Byers et al., 1984; Cohn et al., 1988; Bateman et al., 1988). 
In approximately 85% of those affected with OI, a dominant 
mutation in one of the two structural genes for Type I 
collagen is present (Wenstrup et al. 1990). 
Collagen is the major structural component of the 
extracellular matrix or ECM (Kuhn, 1987). Type I collagen 
accounts for about half the dry weight of bone and over 80% 
of the dry weight of skin, tendons and ligaments (Prockop and 
Kivvirko, 1984). It is a heterotrimer composed of two al and 
one a2 polypeptide chains, designated pro-al(I) and pro-a2(I) 
4 
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respectively. The two individual chains are coded for by the 
well-characterized genes COLlAl and COL1A2, respectively (Chu 
et al., 1985a; Myers et al., 1983; de Wet et al., 1987). Both 
chains are synthesized as procollagen precurser molecules, 
consisting of a central triple helical region made up of a 
repeated Gly-X-Y amino acid sequence and flanking propeptide 
regions at the carboxy and amino termini. 
Collagen Assembly 
Triple-helix formation begins with the aid of sequences 
at the carboxy end of the chains and proceeds in a zipper-like 
fashion toward the amino terminus. The small glycine residue 
in every third position of the central molecule facilitates 
the folding of the three chains into a characteristic triple 
helical configuration allowing tight association of the 
polypeptide chains. Pro line and lysine residues are often 
present in the X and Y positions of the repeat. During helix 
assembly these residues are hydroxylated and some prolyl 
residues are further glycosylated. This post-translational 
modification is important for helix stability and continues 
until triple helix formation is complete (Prockop, 1984; 
Byers, 1989; Byers et al., 1987). Therefore, the extent of 
modification is dependent upon the rate of helix formation 
(Bateman et al., 1988). 
Upon completion of helix formation the procollagen 
molecule is secreted into the ECM and its carboxy and amino 
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propeptide regions are cleaved, leaving a mature collagen 
triple helix with short telopeptides at both ends (Prockop et 
al., 1989). Within the ECM multiple collagen polypeptides are 
arranged end on end, stacked in a parallel fashion and 
crosslinked in a quarter staggered array of collagen 
microfibrils (Bruns and Gross, 1974; Prockop, 1984). Thus, a 
compact and rigid triple helix is essential for the tensile 
strength of mature collagen fibers (Byers et al., 1987; Byers 
1989). The propeptide sequences at the carboxy and amino ends 
are important in chain alignment and secretion of the mature 
collagen molecules into the extracellular matrix (Sandell and 
Boyd, 1990; Prockop et al., 1989; Byers et al., 1987). The 
non-helical telopeptides represent sites where inter- and 
intra-molecular crosslinking occurs in the mature molecule via 
disulfide bonding between cysteine residues. Both the 
appropriate post-translational modification and intermolecular 
crosslinking are important in stabilizing the molecular 
arrangement within collagen molecules and between resultant 
fibrils, affording them thermal stability at body temperatures 
(Kuivaniemi et al., 1991). 
Because the extent of post-translational modification is 
dependent upon the rate of helix formation, mutations in the 
Type I collagen genes which result in a decrease in the rate 
of triple helix formation often result in overmodif ication 
(Bateman et al., 1986; Bonadio and Byers, 1985). This can 
interfere with the folding, processing and formation of 
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thermally stable collagen molecules. Those unstable molecules 
are often rapidly degraded resulting in the production of 
reduced amounts of collagen. 
Type I Collagen Defects in OI 
Many different kinds of Type I collagen defects 
associated with OI have been described. Two general classes 
of mutations have been obeserved: mutations which affect only 
the amount of Type I collagen produced (Barsh & Byers, 1981) 
and mutations that alter the structure of the Type I collagen 
chains. The mildest forms of OI generally result from 
decreased collagen production due to a non-functional or 
partially functional allele (Prockop et al., 1989). The more 
severe phenotypes result from the secretion of structurally 
defective, overmodified procollagen chains that are 
incorportated into mature collagen molecules. Subsequently, 
these interfere with the self-assembly of fibrils (Cohn and 
Byers, 1991; Kuivaniemi, et al., 1991). 
The system of collagen biosynthesis and subsequent 
fibril formation depends upon the principle of nucleated 
growth. such systems begin with a few subunits forming a core 
nucleus that is then self-propagated to generate a larger 
structure. This kind of system is highly vulnerable to 
mutations that cause the synthesis of structurally defective 
but partially functional molecules. In bone, collagen fibrils 
are very densely packed. If an abnormal molecule is 
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incorporated into the fibril the uniform environment which 
contributes to tissue strength is compromised. Not only is 
that molecule less stable, but adjacent molecules are also 
affected. It is also possible that the fibrils which have 
incorporated abnormal molecules may not be mineralized as 
efficiently (Byers, 1990). It is not suprising then, that 
production of structurally defective molecules would cause a 
more severe phenotype. Thus, in terms of clinical symptoms, 
it is less detrimental to produce fewer normal collagen chains 
than to incorporate large numbers of defective ones. 
Among the most commonly studied gene defects in OI are 
point mutations which cause a codon change, most commonly a 
substitution for a Gly residue (Cohn et al., 1990, Wallis et 
al., 1990; Cole et al., 1992) . These substitutions often 
result in the disruption of the triplet pattern or cause 
incorrect exon splicing (Tromp and Prockop, 1988). Deletions 
can also cause splicing defects (Kuivaniemi et al., 1988; 
Tromp and Prockop, 1988) or missing coding information. 
Occasionally insertions have been observed (Byers et al. , 
1988b; Genovese et al., 1989) and sometimes small insertions 
or deletions are responsible for frameshift mutations (Willing 
et al., 1990; Bateman et al., 1989; Pihlajaniemi et al., 
1984). 
Types of OI 
The severity of this disease varies greatly from 
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individual to individual with regard to frequency of fractures 
as well as the extent to which the other symptoms are present 
(Superti-Furga, 1989). Its heterogeneity is reflected at both 
the clinical and molecular levels but its classification into 
one of four types is based mainly on clinical symptoms 
(Sillence, 1979a; Sillence, 1988; Byers et al., 1987; Prockop, 
1984). Most research at the molecular level has focused on 
cases of OI where Type I collagen defects are found. 
Severe perinatal lethal OI, or OI Type II, is the best 
studied form of the disease. It is characterized by neonatal 
dwarfism, multiple fractures leading to severe bone deformity, 
and results in death in utero or shortly after birth 
(Sillence, 1988). It is usually the result of new dominant 
mutations and involves heterogeneous defects in one of the 
Type I collagen genes which primarily disrupt helix formation 
(Byers et al., 1988a; Byers et al., 1988b). For example, point 
mutations which cause a glycine residue to be replaced by a 
bulkier residue in the triple helical portions of the collagen 
molecule not only alter the repeated Gly-X-Y pattern, slowing 
helix formation, but also result in poor secretion of the 
overmodified, thermally unstable procollagen molecule into the 
extracellular matrix (Cohn et al., 1988; Willing et al., 
1988). Those structurally defective molecules, with varying 
degrees of thermal stability, which do get secreted are then 
incorporated into the microf ibril and have consequences for 
the nucleated growth of mature fibrils. For example, one 
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lethal variant with a cysteine for glycine substitution in the 
al(I) chain did not prevent the folding of the triple helix, 
but instead it introduced a "flexible kink" in the helix. This 
delayed fibril formation, reduced the total amount of collagen 
incorporated into the fibrils, and drastically changed the 
morphology of the fibrils (Prockop et al., 1989). 
The substituted residue in Type II OI cases is often 
cysteine or arginine (Vogel et al. , 1987; Bateman et al., 
1987) but substitutions by valine (Lamande et al., 1989; 
Patterson et al., 1989), serine (Lamande et al., 1989) and 
aspartate (Baldwin et al., 1989) have also been described. 
Other mutations such as deletions in the helical coding 
regions of the Type I collagen genes (Barsh et al., 1985; Chu 
et al., 1985b; Willing et al, 1988) and point mutations which 
lead to splicing defects causing missing exons (Tromp and 
Prockop, 1988) have also been described. Additionally, some 
recurring cases of Type II OI, originally thought to be due 
to autosomal recessive inheritance, can be accounted for by 
germ line mosaicism in one parent (Byers et al., 1988a; Cohn 
et al., 1990; Constantinou et al., 1990; Wallis et al., 1990). 
The mild dominantly inherited form of OI, or Type I, also 
involves defects in the structure and/or synthesis of Type I 
collagen. It is characterized by bone fragility which 
decreases at puberty, short stature, blue sclerae, deafness 
and sometimes dentinogenesis imperfecta (Sillence, 1988). In 
a number of studies the phenotype has been shown, by analysis 
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of restriction fragment length polymorphisms (RFLP), to 
consistently segregate with one or the other of the Type I 
collagen genes (Sykes et al., 1986; Tsipouras et al., 1984; 
Falk et al., 1986). Thus, defects in Type I collagen genes are 
clearly responsible for the OI Type I phenotype. In these 
cases however, the triple helix is as thermally stable as 
normal collagen, or only slightly unstable, but the total 
amount of collagen secreted is lower than normal (Rowe et al., 
1985; Bateman et al., 1989; Byers et al., 1988a). In some 
cases, it has been suggested that point mutations which cause 
substitutions in the X or Y positions of the repeat rather 
than in the glycine position, as is seen in Type II cases, are 
responsible for greater thermal stability and perhaps the 
milder phenotype (Bateman et al., 1988). More recently it has 
been shown that one of the Type I collagen gene alleles is 
silent, or non-functional, resulting in production of reduced 
collagen amounts (Willing et. al, 1992). 
The more severe dominantly inherited form of OI, or Type 
IV also involves a variety of Type I collagen defects. It is 
characterized by moderate clinical severity, variable 
deformity of long bones and, in contrast to OI Type I, the 
sclerae of these individuals are pale blue or white (Sillence, 
1988). RFLP analysis has shown that in many cases this form 
of the disease segregates with the COL1A2 gene (Superti-Furga 
et al., 1989; Sykes et al., 1990). Glycine substitutions in 
the triple helical domain of the pro-a2(I) chain are, in fact, 
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associated with many Type IV cases (Wenstrup et al., 1986; 
Wenstrup et al., 1988). These substitutions are often located 
in an analogous position in the helix to those al(I) chain 
substitutions in Type II OI cases, yet they result in the non-
lethal Type IV condition (Cohn and byers, 1991; Superti-Furga 
et al., 1989). 
The progressively deforming, moderately severe form, or 
OI Type III is one of the most common types of OI and the 
least well-characterized with respect to molecular defects. 
Its progressive nature is due to repeated multiple fractures 
leading to severe deformity of the limbs and spine (Sillence, 
1988). Most cases are due to spontaneously-occurring dominant 
mutations while a few are autosomal recessive, when 
consanguinous parents are involved. (Pihlajaniemi et al., 
1984; Bonadio et al., 1990a). There have been some reports of 
substitutions and deletions in the Type I collagen genes of 
OI Type III patients (Bateman et al., 1988; Byers et al., 
1988a; Pack et al., 1989; Byers 1983; Pihlajaniemi et al., 
1984), but there are many cases where no such defects have 
been found (Byers et al, 1987; Byers et al., 1988a; Steinman 
et al., 1988; Beighton et al., 1988; Wenstrup et al., 1990). 
The variability of the clinical symptoms within this form of 
OI suggests further genetic heterogeneity within the group. 
RFLP analysis of several of the recessive pedigrees for Type 
III OI have shown that this form of OI is often unlinked to 
either of the Type I collagen genes (Byers et al., 1987; 
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Aitchison et al., 1988). 
It has been suggested that for those cases where 
mutations in the Type I collagen genes have been excluded, 
defects in other ECM genes could be responsible for expression 
of the OI phenotype. Other genes encoding bone-specific 
proteins which may interact with Type I collagen, are likely 
candidates (Byers, 1990). 
OI Heterogeneity: A Potentially Polygenic Disease 
Although large numbers of OI cases have been studied at 
the molecular level there is still very little understanding 
of how the specific defects in Type I collagen contribute to 
the OI phenotype. It has not been possible to correlate 
specific kinds of molecular defects with particular OI 
phenotypes. The different forms of the disease cannot always 
be distinguished by which of the Type I collagen genes 
contains the defect nor can they always be associated with the 
location of the defect within certain domains of the collagen 
propeptide. There are a number of cases in which similar 
defects, such as glycine substitutions, map very close to each 
other in the same propeptide chain yet are associated with 
drastically different phenotypes (Tenni et al., 1988; 
Constantinou et al., 1990). Glycine substitutions outside the 
triple-helical domain have been identified in both mild and 
severe cases (Byers, 1990). There is an example of 3 cases 
where small insertions or deletions, all located in the c-
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propeptide caused frameshift mutations which produce three 
phenotypes ranging from mild to severe {Willing et al., 1990; 
Bateman et al., 1989; Pihlajaniemi et al., 1984). There are 
also many cases where multiple members of a family carry the 
same Type I collagen defect and show a wide variation of 
severity, even being asymptomatic {Superti-Furga et al., 1989; 
Sykes et al., 1990). 
It is possible that factors such as local chain 
structure, domain functions and molecular interactions in the 
final collagen polypeptide could modify the effect of specific 
substitutions {Byers, 1990; Cohn et al., 1988). However, as 
is clearly indicated in the above situations, the variable 
severity of symptoms cannot be wholly attributed to a lack of 
understanding of the functional domains of the Type I collagen 
molecule. Defects in other ECM components, including other 
collagen types, which interact with the various domains of 
Type I collagen could clearly affect the OI phenotype. 
Other Collagen Types 
There are at least 15 other collagen types in addition 
to Type I collagen. They are composed of multiple distinct 
polypeptide chains, and thus they are coded for by more than 
25 genes {Miller and Gay, 1987). In addition to the structural 
role the "classical" or "f ibrillar" collagens are known to 
play in providing a scaffolding for underlying tissues, recent 
discoveries have indicated that other collagen types have 
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additional properties dictated by the multiple domains in 
their polypeptides. However, very little is known about how 
their associations/interactions contribute to the structural 
integrity of the extracellular matrix. Collagens are defined 
by a triplet repeat, the presence of the modified amino acids 
hydroxyproline and hydroxylysine, and by the formation of a 
triple helical structure (Byers, 1989; Sandell and Boyd, 
1990). They can be classified into distinct groups. 
The first group consist of the classical or fibrillar 
collagens (Types I, II, III, V and XI). They all contain three 
polypeptide chains, with a monomer size greater than 95,000 
daltons and long, uninterrupted triple-helical domains, 
approximately 300 nm in length, containing the characteristic 
Gly-X-Y amino acid repeat (Kuhn, 1987). They are all expressed 
in a tissue specific manner and all participate in the 
formation of the characteristic fibrils known to contribute 
to the structural framework and strength of connective tissue. 
Their genes share a highly-conserved exon-intron organization 
(Chu et al., 1984). The majority of the exons in the triple 
helical coding regions are 54 bp, or multiples of 54 base 
pairs and all of them contain integral numbers of the basic 
Gly-X-Y repeat, beginning with the codon for glycine (Sandell 
and Boyd, 1990). The highly interrupted coding sequences 
contain more than 50 exons resulting in genes between 18 and 
40 kilobases (de Wet et al., 1987; Chu et al., 1985a; 
Tsipouras and Ramirez, 1987; Myers et al., 1981). The coding 
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sequences are divided into a nearly identical number of small 
exons, and most introns regardless of size, are located in 
homologous positions in each gene (Ramirez et al., 1985; 
Bernard et al., 1988). In addition, all of the fibrillar 
collagens arise from procollagen precursors and undergo 
proteolytic removal of terminal extensions as was described 
for Type I collagen above (for a complete review see Kuhn, 
1987). 
All collagens other than the f ibrillar collagen types 
described above can be referred to as non-fibrillar collagens. 
These collagens do not form long fibrils and all contain 
multiple interruptions in the Gly-X-Y repeat. The genes coding 
for these collagens contain few 54 bp exons (Sandell and Boyd, 
1990). They can be divided into subgroups based on their 
specific structural features and possible functions; however, 
their placement in one group is not necessarily exclusive. 
The large nonfibrillar, minor collagen types IV, VI and 
VII again have monomer chain sizes that are greater than 
95,000 daltons, but they all have at least one interruption 
in the Gly-X-Y repeat within the triple helical domain 
(Sandell and Boyd, 1990) and large terminal globular domains. 
The interruptions allow the molecules flexibility which is not 
possible for the fibrillar collagens (Hofmann et al., 1984). 
Although this group in general is not well characterized, 
analysis of the genes for Type IV, a basement membrane 
collagen, has shown that the exon sizes and overall intron-
17 
exon patterns are very different from the 54 bp exon pattern 
of the fibrillar collagens (Soininen et al., 1988; Soininen 
et al., 1989). In addition, these collagens tend to aggregate 
through end-to-end association of monomer (Timpl et al., 1981) 
or dimer units rather than by the lateral, quarter staggered 
association necessary for fibril formation. 
Type VI collagen is a highly disulfide bonded, 
microf ibrillar component present in human blood vessels and 
in the myocardium (Chung et al., 1976; Bashey et al., 1992) 
as well as many other "soft" connective tissues (Karkavelas 
et al., 1988). This molecule appears to be distributed in 
tissues where continuous contraction and relaxation, such as 
that seen in the heart, would warrant a very flexible ECM 
component that would allow the distribution of this sort of 
stress (Bashey et al., 1992). Type VII collagen, the major 
protein of anchoring fibrils in epidermal basement membrane, 
also exhibits properties that could contribute to tissue 
flexibility (Ryynanen et al., 1991). 
The "short-chain" collagen Types VIII and X have monomer 
chains which are half the length of the f ibrillar collagens 
(Apte et al, 1992) and have a distinct gene organization. 
These collagens share common structural features in that both 
contain 8 interruptions of the helix of similar sequence, 
length and relative locations (Ninomiya et al., 1990; 
Yamaguchi et al., 1989). The small 5 kb gene for chick al(X) 
collagen contains only 3 very large exons and no introns 
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separating its triple helical coding sequences (Sandell and 
Boyd, 1990). The 6kb human al(X) gene contains only 2 exons, 
one very large and one very small (Thomas et al., 1991). In 
all of these genes one large exon encodes the entire triple 
helical coding region (Yamaguchi et al., 1991; Thomas et al., 
1991). The genes of the short chain collagens share almost 
complete sequence identity in some regions, such as the 3' 
half of the non-collagenous (NCl) domain (Muragaki et al., 
1990). In vitro studies show that Type X collagen forms a 
hexagonal lattice similar to that formed by Type VIII collagen 
in Descemet's membrane (Apte et al., 1992). Although the exact 
function of these collagen types is unknown, Type X collagen, 
expressed in hypertrophic chondrocytes, is somehow necessary 
for normal bone development (Thomas et al., 1991). 
"FACITs" Collagens 
The final subgroup, the fibril-associated collagens with 
interrupted triple helices or "FACITs" collagens (Olsen et 
al., 1988), include Types IX,, XII, XIV and XVI (Gordon et 
al., 1989; Gordon et al., 1991; Pan et al., 1992). Many of 
these collagens have properties which suggest their ability 
to interact with other collagens and ECM components. These 
interactive properties, along with complex regulatory 
mechanisms, tissue specificity and developmentally regulated 
gene expression make them particularly interesting candidates 
for factors which mediate/diversify the function of the major 
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fibrils in different tissues. It is therefore possible that 
mutations in genes whose products have properties like these 
could contribute to the OI phenotype. 
All of these collagens, as well as Types VIII and X, have 
monomer chain sizes less than 95, 000 daltons, with the 
exception of Type XII (Pihlajaniemi and Tamminen, 1987), and 
have many interruptions in the Gly-X-Y repeat. They are made 
up of multiple collagenous domains (COL) separated by distinct 
non-collagenous (NC) regions. Each of these regions is 
designated by a number indicating its location in the complete 
polypeptide. The "FACITs" collagens do not undergo proteolytic 
processing and are thus not secreted as procollagens (Shaw and 
Olsen, 1991). Although the FACITs all share these common 
structural features, their sizes and primary structures vary 
greatly (Pan et al., 1992). This collagen group shows a wide 
variation in gene structure and overall intron-exon 
organization. They contain few 54 base pair exons and the 
exons often do not contain integral numbers of the Gly-X-Y 
repeat. All of these collagens occur in conjunction with other 
fibrillar collagen types, and are somehow "associated" with 
the surface of the fibril. 
Type IX collagen is considered a proteoglycan with 
collagenous properties (Noro et al., 1983) • Found in cartilage 
and corneal stroma, it contains three collagenous and four 
non-collagenous domains. Three genes code for the heterotrimer 
(Ninomiya, 1985). The gene for chicken al(IX) collagen is 100 
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kb, and contains short exons and multiple large interruptions 
in its triple helical coding sequences. In contrast, the 
a2 (IX) gene, about 10 kb in length, contains more exons, 
smaller intrans, and therefore a much higher exon density 
(Ninomiya et al., 1990). The a2 chain also contains the 
covalently bound glycosaminoglycan (GAG) side chain. Despite 
these differences, the size and location of the exons coding 
for the multiple triple-helical regions, as well as most of 
the non-collagenous regions, are structurally homologous. The 
recent isolation of cDNA clones of the chick a3 (IX) chain 
indicate an overall structure similar to that of homologous 
regions of al(IX) and a2(IX) (Brewton et al., 1992). 
Type IX collagen is found to be crosslinked to Type II 
collagen molecules in cartilage (Vaughan et al., 1988) and is 
arranged in a periodic manner along the surface of the fibril 
projecting its third triple-helical, COL3, and NC4 globular 
domain into the per if ibrillar matrix (Olsen et al., 1988; 
Gordon et al., 1991). The large globular amino-terminal NC4 
domain of the cartilage al (IX) molecule is significantly 
shorter and very different in structure in embryonic cornea. 
Tissue-specific promoter usage and alternative splicing is 
likely responsible for this variation (Gordon et al., 1989). 
The tissue-specific variation seen in the perif ibrillar 
extension of the Type IX polypeptide affords the major Type 
II collagen molecule the ability to interact in a tissue 
specific manner with other collagen types and ECM components. 
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Type IX collagen also contains an attachment site in the 
a2 chain for a chondroitin sulfate side chain in its NC3 
domain, suggesting its role as a proteoglycan as well as a 
collagen. This GAG side chain is also in contact with the 
major Type II fibrils of cartilage, thus perhaps providing an 
additional way to facilitate interaction between the collagen 
molecules and other ECM components (Vaughan et al., 1988). 
Type XII collagen was originally isolated from embryonic 
chick tendons (Dublet and van der Rest, 1987; Gordon et al., 
1987) a tissue whose major fibril is Type I collagen. It has 
two short triple-helical domains and three non-collagenous 
domains (Gordon et al., 1990). Type IX and Type XII are about 
50% identical at the protein and gene levels and have multiple 
conserved cysteine residues in the NCl, COLl and NC2 domains 
(Gordon et al., 1987). In contrast to Type IX, Type XII is a 
homotrimer of three identical a-chains and does not contain 
a glycosaminoglycan side chain. However, it does contain an 
amino terminal globular domain, NC3, which is similar to, but 
much larger than NC4 of al(IX) (Dublet et al., 1989). The 
intron/exon structure of portions of al(XII), specifically 
COLl, NC2 and COL2, is homologous to that of the al(IX) and 
a2(IX) chains (Gordon et al., 1989; Gordon et al., 1990). In 
addition to these Type IX-like regions (which comprise only 
7.7% of the molecule), recent data reveal that the complete 
Type XII collagen is a chimeric molecule with multiple 
functional domains including reiterated fibronectin type III 
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motifs, von Willebrand factor A motifs, and Arg-Gly-Asp cell 
adhesion sites (Yamagata et al., 1991). 
Type XIV collagen fragments were recently isolated from 
fetal bovine skin and tendon (Dublet & van der Rest, 1991) and 
embryonic chick skin. This homotrimeric collagen also appears 
to be another FACITs since the structure of its collagenous 
domains is similar to that of Type XII, and to a lesser extent 
Type IX collagen (Gordon et al., 1991; Aubert-Foucher et al., 
1992) . Electron microscopic studies suggest that Types XII and 
XIV collagen could be similar in size and shape as well 
(Dublet and van der Rest, 1990). In Type XIV as in Type XII, 
the triple helical domains comprise less than 15% of the 
intact molecule (Aubert-Foucher et al., 1992). 
The recently described human Type XVI collagen gene again 
resembles the structure of the other fibril-associated 
collagen Types IX, XII and XIV (Pan et al., 1992). Many of its 
10 collagenous domains contain interruptions of the Gly-X-Y 
pattern and these domains are separated by 11 short non-
collagenous stretches. Again, the COLl and the amino terminal 
NC domain is similar to that of other FACITs collagens. In 
addition, its cysteine-rich non-collagenous domains resemble 
those found in the ~ elegans cuticle collagen. This 
similarity, and the expression of Type XVI in epidermal 
keratinocytes as well as dermal fibroblasts, have implied its 
possible function in the epidermis. The predicted amino acid 
sequence also contains three potential N-glycosylation sites 
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(Asn-X-Thr/Ser) and three Arg-Gly-Asp sites (signal for cell 
adhesion). It too is thus a multi-domain molecule with both 
collagenous and non-collagenous properties. 
Most mammalian tissues express more than one type of 
collagen although one is usually predominant. Type V collagen 
is frequently associated with both Types I and III (Fessler 
and Fessler, 1987) and immunohistochemical studies have shown 
close association, in vivo, of Type V fibrils with Type I 
fibrils and with basal laminae (Martinez-Hernandez et al., 
1982; Fitch et al., 1984). It appears that Type V fibrils are 
somehow involved in regulating the diameter of Type I fibrils 
(Birk et al., 1988) . A similar function has also been 
suggested for Type XI which is associated with Type II fibrils 
in cartilagenous tissue (Eyre and Wu, 1987). 
The non-fibrillar, FACITs collagen Types IX and XII are 
are also structurally, genetically and perhaps functionally 
related (Dublet and van der Rest, 1987; Gordon et al., 1987). 
It has been suggested, due to their structural similarities, 
that Type XII may align similarly along the surface of Type 
I and V fibrils in bone as Type IX does with Type II and XI 
fibrils in cartilage (Ninomiya et al., 1990). Immunofluores-
cence studies have indeed found Type XII collagen only in 
tissues that contain Type I collagen, but not bone (Sugrue et 
al., 1989). TWo Type XII-like collagens, likely to be Type XIV 
collagen, have been localized to the surf ace of banded 
collagen fibrils of human and calf tendon and skin (Keene et 
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al., 1991). It is possible that Type XIV in bone, and Type XII 
in non-bone tissues serve similar functions in different Type 
I collagen-containing tissues. 
Once described as a "short-chain" collagen, low molecular 
weight collagen Type XIII has features of the non-f ibrillar 
Types IV and IX (Pihlajaniemi et al., 1987). Most of the exons 
of the al(XIII) gene are not multiples of 54 bp and it encodes 
three collagenous and four non-collagenous domains 
(Pihlajaniemi and Tamminen, 1990). The exons all begin with 
a complete codon for an amino acid, a feature found in the 
genes for the fibrillar collagens (Tikka et al., 1988). 
Therefore, this collagen has both fibrillar and non-fibrillar 
collagen features. This was the first collagen described to 
undergo complex alternative splicing. As many as 5 alternative 
splice sites have been identified and at least 2 species of 
mRNA transcripts are produced by the use of alternative 
transcription initiation sites as well as alternative splicing 
(Pihlajaniemi and Tamminen, 1990) . This gene also contains one 
exon which encodes a unique Gly-X-Y repeat extending into a 
domain that is not triple helical. (Tikka et al., 1988) . 
Therefore, Type XIII collagen has a structure which is 
different from all other collagen types. 
As more unique features of the non-f ibrillar collagen 
genes are discovered, the diverse domains of these collagen-
like ECM components imply functions beyond the traditional 
structural role attributed to fibrillar collagens. There are 
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likely to be important interactions of these molecules with 
the fibrillar collagens and with other ECM components in 
determining the connective tissue type, its basic properties, 
structural integrity, and capacity to withstand stress. 
Additional collagen-like genes continue to be discovered. 
Recent studies have shown that a pro-a2(I) cDNA probe detects 
two previously-undescribed loci in a collagen-like gene(s) 
other than the already-characterized f ibrillar collagen genes 
(Doering et al., 1990). Deletions of heterogenous size have 
been detected at one or the other of these sites in genomic 
DNA of Type III OI patients. The deletions are significantly 
more prevalent in these patients than in the normal population 
and frequently occur spontaneously in patients who have no 
clear family history of the disease (Doering et al., 1990). 
such correlations suggest that these collagen-like deletion 
sites could be contributing to the OI phenotype. 
One site, detected as a 4. 6 kb Hind III restriction 
fragment in normal individuals, has been localized to 
chromosome 17 (Cammarata et. al., 1991). The cloning and 
sequencing of this fragment will allow identification of the 
gene product of this locus, characterization of the deletion 
site in OI patients, and thus ultimately an understanding of 
how mutations at this locus might play a role in the OI 
phenotype. 
MATERIALS AND METHODS 
overall Approach 
In order to characterize the new collagen locus, a Charon 
21A phage library containing Hind III restriction fragments 
of human chromosome 17 was screened for a 4.6 kb collagen 
sequence-containing fragment. Positive phage isolates were 
plaque purified and the insert-containing phage DNA isolated. 
The 4.6 kb insert was recloned into a plasmid vector so that 
a preliminary restriction map could be constructed. This 
allowed the subcloning of smaller fragments, containing triple 
helical coding sequences, to be sequenced. Sequence 
comparisons using Genetics Computer Group software (Devereux 
et al., 1984) were performed to compare these sequences to 
other known collagen genes and collagen-like sequences in 
order to identify the collagen group that the new locus 
represents. 
Library Screening 
The previously described pro-a2 (I) cDNA clone Hf32 (Myers 
et al., 1981) was used to screen a human chromosome 17 library 
(LL17NS02/ ATCC#57759) obtained from American Type Culture 
Collection, Rockville, MD. This phage library was constructed 
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in the Charon 21A vector with Hind III digested restriction 
fragments of human chromosome 17. The ~ coli bacterial strain 
JM109 was infected with the recombinant phage particles 
(Benton and Davis, 1977) and incubated at 37°C overnight on 
NZCYM agar plates (Sambrook et al., 1989). Plaque lifts to 
nylon membranes (NEN, Bethesda, MD) and lysis of the membrane-
bound phage were done according to the manufacturer's 
instructions. A total of 106 phage clones were screened. 
Plaque purification was carried out using previously described 
methods (Sambrook et al., 1989). 
Nick Translation and Hybridizations 
The cDNA clone Hf32, digested with EcoRI and PstI, was 
32P-labelled by nick translation (Rigby et al., 1977) to an 
average specific activity of 4.5 x 108 cpm/µ.g. Prehybrid-
ization was carried out for a minimum of 5 hours at 37°C 
(Doering et al., 1982; Rosenthal and Doering 1983) in 
hybridization solution (50% formamide, 0.9 M NaCl, 50mM Tris 
pH7.5, 1% sos, lOug/ml denatured~ coli DNA). Denatured nick 
translated probe was added to the prehybridized membranes and 
incubation continued at 37°C for a minimum of 16 hours. 
Membranes were washed twice for 10 minutes at room temperature 
in 2X SSC (lX SSC is 150 mM NaCl, 15mM sodium citrate, 0.1 mM 
EDTA), twice for 30 minutes at 50°C in 2X SSC, 1% sos and 
twice for 30 minutes at room temperature in 0.5X SSC. 
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Autoradiography was done using Kodak XAR X-ray film and Dupont 
Lightning-Plus intensifying screens when necessary. 
Rehybridization of any additional probes to previously 
hybridized membranes first required removal of the original 
probe by very high stringency washes. The membrane was first 
washed with a O. 4M NaOH solution, then with O. lXSSC, O. 2M 
Tris-HCl, 0.1% sos, in a shaking water bath at 42° C for 30 
minutes. If the probe was not sufficiently removed this 
procedure was repeated and/or a second method was carried out. 
The additional method required boiling the membrane in a 
solution of O. lxSSC, 1% SOS for 3 O minutes. This procedure was 
also repeated as necessary to completely remove the probe. 
DNA Isolation 
The purified recombinant phage DNA was isolated by the 
standard plate lysate method (Maniatis et al., 1982) with the 
following modifications: Harvested phage particles were 
treated with RNase A and DNase I at a final concentration of 
10 µg/ml and 5 µg/ml respectively. The PEG precipitated phage 
particles were incubated overnight on ice. After addition of 
SDS/EDTA, lysis was carried out for 1 hour at 68°C. 
Isopropanol precipitation was carried out overnight at -20°c. 
Plasmid purification was carried out using Qiagen Tip-100 
anion exchange columns (Chatsworth, CA) according to the 
manufacturer's instructions. 
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Restriction Mapping; Alu Repetitive Sequence and Exon 
Localization 
Restriction mapping was carried out by established 
methods using single, double and triple digests (Doering, 
1977; Peterson et al., 1980; Rosenthal et al., 1984). All 
restriction enzymes were purchased from Bethesda Research 
Laboratories (Bethesda, MD) or Promega Biotech (Madison, WI) 
and used in the suppliers' recommended buffers. Restriction 
digests were stopped by addition of SOS and EDTA to final 
concentrations of 0.5% and lOmM respectively. Gel 
electrophoresis was carried out using 1% or 1.2% agarose gels 
(Rosenthal and Doering, 1983) and the DNA was transferred to 
NEN (Boston, MA) Gene Screen Plus membranes using the alkaline 
transfer method (Reed and Mann, 1985). DNA size markers were 
lambda phage DNA digested with HindIII and phi-X 174 phage DNA 
digested with HaeIII. Triple helical coding regions were 
identified using the Hf32 probe and hybridization conditions 
described above. Localization of Alu repetitive sequences was 
done using the Alu probe Blur 8 (Deininger et al., 1981) . 
Hybridization conditions were the same as those described for 
the Hf32 probe above except that the hybridization solution 
contained 1.0M NaCl instead of 0.9M as for Hf32. 
Subcloning and DNA Sequencing 
The 4. 6 kb phage DNA insert and the 1. 6 kb EcoRI/PstI and 
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1. 5 kb EcoRI / SmaI restriction fragments containing triple 
helical coding sequences were subcloned by standard methods 
(Sambrook et al., 1989) into the pUC13 (Vieira and Messing, 
1982) and pGEM7Zf+ (Promega Biotech, Madison, WI) vectors. 
These subclones, p4.6EP and p4.6ME respectively, were 
sequenced by the dideoxy method (Sanger et al., 1977). The 
double-stranded template and primer were denatured and 
reannealed as follows prior to extension/termination 
reactions. Three micrograms of template DNA and o. 5 pmol 
primer DNA were combined in a total volume of 20.0 µl. NaOH 
and EDTA were added to a final concentration of o. 2M and o. 2mM 
respectively and the mixture was incubated for 5-6 minutes at 
85°C. The tube was immediately placed on ice, and 6.0 µl of 3M 
NaOAC, pH 5.2 and 60.0 µl 100% EtOH were added to precipitate 
the denatured DNA. This solution was placed at -20°C for 20 
minutes. The DNA was pelleted by centrifugation at 10,000 rpm 
in an SHMT rotor (Sorvall/E.I. duPont, Newtown, CT) for 20 
minutes and washed carefully with 70% EtOH. The dried DNA 
pellet was resuspended in distilled H20 and reannealed 
(incubated) for 15 minutes at 37°C (p4.6EP) or 5 minutes at 
37°C followed by 5 minutes at room temperature (p4.6ME). 
The extension and termination reactions were carried out 
according to the manufacturer's instructions for sequencing 
double stranded DNA using the "Sequenase" kit (United States 
Biochemical Corp., Cleveland, OH) and/or the "AmpliTaq" 
sequencing kit (Perkin-Elmer Cetus, Norwalk, CT) . The DNA was 
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tagged by including 35S-labelled dATP nucleotides during the 
extension reaction. When obtaining sequence information from 
inserts in the pUC13 vectors the -40 primer adjacent to the 
EcoRI site was used (see Figure 7c). Sequence extension began 
from the EcoRI end of the insert and continued to the left 
toward the helical coding region. When obtaining information 
from the pGEM7Zf+ clones, the T7 primer was used (Figure 7d) . 
Again, sequence extension was from the Eco RI site, or in the 
case of the nested deletion clones (Figure 7e), sequences 
adjacent to this site and proceeding to the left through the 
helical coding region. The nucleotide analogue deaza-dGTP 
(Perkin-Elmer Cetus, Norwalk, CT) was also used in the 
extension reactions, according to the manufacturer's 
instructions, in conjunction with 40% formamide gels, for 
confirming sequence in regions with complex secondary 
structure. 
Generation of Nested Deletions 
The subclone p4.6ME was used as a template to generate 
nested deletions by exonuclease III digestion from the Eco RI 
site. This procedure was carried out by using the "Erase-a-
base" system (Promega Corporation, Madison, WI) according to 
the manufacturer's instructions. Three overlapping clones, 
p4.6ME-5, p4.6ME-7 and p4.6ME-9 with deletions of appropriate 
sizes (Figure 7e) were chosen for further sequencing. 
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Sequencing Gels 
Sequencing gels containing either 8% or 6% acrylamide/bis 
(37.5:1) and 7M urea were used to obtain most of the 
sequencing data. In order to sequence regions of secondary 
structure formamide was added to a final concentration of 40% 
when necessary. After electrophoresis, the sequencing gel was 
soaked for 15 minutes in 10% acetic acid/ 10% methanol solution 
or 10% acetic acid/20% methanol for formamide gels. It was 
then transferred to Whatman 3MM filter paper by established 
methods (Kozak et al., 1991), dried in a gel dryer (Bio-Rad 
Laboratories, Hercules, CA) for a minimum of 2 hours and 
autoradiographed. The entire sequence was read a minimum of 
3 times from independent gel runs in order to confirm its 
accuracy. Sequence analysis was done with the aid of the VAX 
network system (Loyola University Chicago) and the Genetics 
Computer Group sequence analysis program, version 7.1 
(Devereux et al., 1984). 
RESULTS 
Isolation and Confirmation of Cloned Sequences 
In order to characterize the new collagen-like Site 2 
locus, a Charon 21A lambda phage library containing HindIII 
restriction fragments from human chromosome 17 was screened 
for the 4. 6 kb collagen sequence-containing fragment. At least 
106 plaques were screened with the 32P-labelled a2 (I) cDNA, 
Hf32, and 107 positives were identified. The high number of 
positives was not suprising since a full chromosome's worth 
of fragments is contained in 1. 4 x 104 clones. Twelve 
positives were picked for plaque purification. Purification 
required plating the phage particles at the appropriate 
density (approximately 100-200 plaques per plate) so that 
individual positive plaques were well separated and could be 
easily identified and isolated. This assures that each 
positive isolate contains a homogeneous population of phage 
particles representing a single clone. Five independent 
isolates were identified and DNA was prepared from them. When 
digested with HindIII, three of the clones were found to 
contain a 4.6 kb insert, that hybridized strongly with the 
a2(I) cDNA probe (Figure la). The other two clones contained 
a 4.4 kb and a 6.0 kb insert respectively, that also 
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hybridized with the Hf32 probe (Figure la). 
The blot of the HindIII digested phage isolates was 
stripped and rehybridized with the al(I) cDNA probe, Hf677, 
under higher stringency conditions, (1XSSC/65°C). There was no 
hybridization of the 4. 6 kb cloned inserts but there was 
hybridization to both the 4.4 and 6.0 kb inserts (Figure lb). 
These results confirm that the 4.6 kb fragment is not a member 
of the already characterized COLlAl gene which is also located 
on chromosome 17. Use of high stringency conditions ensures 
this because a genuine COLlAl sequence would cross-hybridize 
even under these high stringency conditions. Positive 
hybridization of the al(I) probe, even at high stringency, to 
the cloned 6.0 kb fragment confirm that this is the same 6.0 
kb fragment known to be a member of the COLlAl gene (Barsh et 
al., 1984). Although the 4.4 kb insert is also detected by 
Hf677, there is no fragment of that size in the COLlAl gene. 
Therefore, the nature of this clone is undetermined. No 
further study has been done on this isolate. 
The above hybridization results confirm that the 4.6 kb 
cloned fragment represents a distinct locus and is not part 
of the COLlAl gene. The sequences within the 4.6 kb fragment 
thus represent a new human collagen-like locus on chromosome 
17 which has not previously been described. 
DNA from an isolate containing a 4. 6 kb insert was chosen 
for further study. It was first used to confirm that this was 
indeed a clone of the 4.6 kb HindIII fragment characteristic 
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of Site 2. Hybridization of this phage isolate to HindIII or 
PstI digested genomic DNA of a normal and an OI III affected 
individual revealed a smear of hybridization in all lanes 
under low stringency conditions {Figure 2a) . This 
hybridization smear indicated that the cloned DNA contained 
repetitive sequences dispersed throughout the genome, as well 
as the originally identified collagen-like sequences. 
When the blot was rewashed at higher stringency {O. lXSSC, 
65°C) the smears were greatly diminished and distinct bands 
could be visualized. In the normal individual the 4. 6 kb 
HindIII and 5.2 kb PstI fragments characteristic of Site 2 are 
detected by the probe (Figure 2b, lanes 2 & 4). The detection 
of a doublet in these lanes suggests that this individual is 
heterozygous for a 300 bp deletion at this locus. These were 
the only fragments detected in the genomic DNA of the normal 
individual. In the DNA of the OI affected individual the probe 
detects only a 4.4 kb fragment in the HindIII digest or a 5.0 
kb fragment in the PstI digest. This individual is known to 
be homozygous for a 200 bp deletion at this locus. The 
hybridization of the phage isolate probe to only these 
fragments representing the collagen-like locus confirmed that 
the 4. 6 kb fragment characteristic of this locus had been 
successfully cloned. 
To determine the identity of the repetitive sequences 
contained within this clone the southern blot containing 
HindIII digested phage isolate DNA was hybridized to the Alu 
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sequence probe Blur 8 (Figure le). The positive hybridization 
indicates that at least some of the repetitive sequences in 
the 4.6 kb clone are members of the Alu dispersed family. 
Restriction Mapping of the HindIII Fragment Cp4.6) 
In order to facilitate the mapping and characterization 
of the phage isolate, the 4.6 kb insert was excised from the 
HindIII site of Charon 21A and recloned at the HindIII site 
of the pUC13 plasmid vector, forming p4. 6. Restriction mapping 
was carried out by established methods (Doering, 1977; 
Peterson et al. , 1980; Rosenthal et al. , 1984) . A complete map 
of the 4.6 kb cloned fragment is shown in Figure 3. Southern 
blots of restriction digests, hybridized with the Hf32 cDNA 
probe, allowed localization of the triple helical coding 
region to an 800 bp region extending from EcoRI to PvuII 
within a 1. 6 kb EcoRI to PstI restriction fragment {Figure 4) . 
Clearly the 1.6 kb EcoRI/PstI fragment hybridized with the 
probe (Figure 4a, lane 4) indicating that this region contains 
helical coding sequences. In p4.6 neither the HindIII/PstI 
fragment to the left of the helical coding region (see Figure 
3), nor the HindIII/EcoRI fragment to the right (data not 
shown) of the 1.6 kb EcoRI/PstI fragment, hybridized with the 
Hf32 probe. Upon double digestion of p4.6 by the enzymes Aval! 
and HindIII a doublet is produced at the 1.4-1.5 kb position. 
The upper fragment of the doublet is a HindIII/AvaII insert 
fragment shown to the left of the triple helical coding region 
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in Figure 3. When the Southern blot of this digest was 
hybridized with Hf32, only the lower, vector fragment of the 
doublet was detected (Figure 4b, lane 5). There is also a 
PstI/PvuII subfragment contained within the HindIII/AvaII 
fragment which does not hybridize (Figure 4b, lane 7). Thus, 
lack of hybridization to the HindIII/AvaII and PstI/PvuII 
fragments allowed localization of the helical-coding region 
solely to the EcoRI/PvuII portion of the EcoRI/PstI fragment. 
The al (I) probe Hf677 was also rehybridized to the same 
Southern blot in order to determine if any other regions 
contained triple helical coding sequences. No additional 
regions were identified with this probe (data not shown). 
The presence of collagen-like sequences in the 1.6 kb 
EcoRI/PstI restriction fragment was reconfirmed by its 
susceptibility to digestion with Sau96I. This approach has 
previously been used in characterizing other collagenous 
protein coding regions (Vasios et al., 1987). The recognition 
sequence of this restriction enzyme is GGNCC. This is the same 
sequence that codes for the amino acids Glycine (GGN) and 
Proline (CCA or CCT). Thus, because glycine is present as 
every third residue and proline is often in the X position of 
the collagen triplet, triple helical coding regions are 
extremely suseptible to digestion with this enzyme. The clone, 
p4.6, was triple digested with Sau96I, EcoRI and PstI so that 
the effect of Sau 961 on the 1.6 kb EcoRI/PstI fragment could 
be examined. No sequences of the EcoRI/PstI fragment greater 
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than 200 bp remained intact (Figure 5, Lane 3), indicating 
that multiple Sau96I sites were present in this restriction 
fragment. When p4.6 is digested with EcoRI and PstI only, 4800 
bp (see Figure 4a, lane 4) and 750 bp fragments are generated 
in addition to the 1600 bp fragment. After digestion with 
Sau96I the 4800 bp fragment remains only as a 2000 bp fragment 
containing both insert and vector sequences to the right of 
the EcoRI/PstI fragment (see Figure 3). The pUC13 vector 
contains multiple Sau96I sites which, upon digestion produce 
fragments much smaller than 2 kb. Therefore, this fragment 
must span the vector-insert junction. The distance from EcoRI 
to HindIII on the right however, is larger than 2000 bp. Thus, 
there must be additional Sau96I sites close to the EcoRI site 
in the right-hand EcoRI/HindIII fragment of the clone. 
Hybridization of a Southern blot containing various 
restriction digests of p4.6 to the Alu sequence probe Blur 8 
allowed the identification of a minimum of three restriction 
fragments containing Alu repetitive sequences (Figure 6). 
These sequences are present in the 1.6 kb EcoRI/PstI helical-
coding fragment, and on both sides of this fragment. The 
flanking fragments were: the 800 bp SstI/HindIII fragment and 
a more weakly hybridizing 800 bp HindIII/Pst I fragment. The 
850 bp PstI/PvuII portion of the 1.6 kb helical-coding region 
contained all the Alu sequences within this fragment (data not 
shown). These repetitive sequence regions are indicated by an 
asterisk in Figure 3. 
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Subcloninq and Sequencing 
The helical-coding region of p4.6 remains the focus of 
the subsequent data in this thesis because its collagen-like 
nature is of greatest interest. The correlation between 
deletions in this region and Type III OI (Michaels, 
unpublished) make it of particular interest. In order to 
facilitate the fine structure mapping and sequencing of the 
helical-coding region, the EcoRI/PstI fragment was subcloned 
into the pUC13 plasmid vector. A schematic diagram 
illustrating the construction of this subclone (p4.6EP), and 
subsequent constructs used in sequencing the helical region, 
is presented in Figure 7. This arrangement simplified 
restriction digest patterns and placed the EcoRI/PstI fragment 
directly adjacent to vector sequences for which sequencing 
primers were available (Figure 7c) . Southern blot hybridiza-
tions of Hf32 to restriction digests of this subclone 
confirmed the presence of at least two regions containing one 
or more AvaII sites (recognition sequence: GGACC). The first 
site, estimated at a position 150-200 nucleotides to the left 
of EcoRI, marks the point at which the triple helical coding 
region begins. At a position 680 bp from EcoRI, the most 
distal PvuII site defines the approximate endpoint of the 
triple helical coding region (see Figure 3). 
The next goal of this project was to sequence this triple 
helical coding region. Although it was clear that the region 
did not begin until the first AvaII site, the presence of 
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multiple AvaII sites very close to each other, and the lack 
of other convenient restriction sites, made subcloning only 
the immediate coding region impossible. Therefore dideoxy 
sequencing using the "Sequenase" kit (U.S. Biochemical Corp.) 
was carried out beginning at the 11 -40 universal primer" site 
adjacent to the EcoRI cloning site (Figure 7c). 
At position 230 (230 nucleotides to the left of EcoRI of 
Figure 3), the first AvaII site was reached. This marked the 
beginning of the triple helical coding region. Approximately 
300 nucleotides of sequence was determined using the Sequenase 
kit (Figure 8) . At that point the ability to resolve sequence 
using the -40 primer was lost. In addition, the limitations 
of the Sequenase method prevented the determination of 
sequence in areas of complex secondary structure near the 
AvaII sites (see Figure 9a). This sequence not only has a 
repetitive nature but is also very GC rich. DNA polymerase I, 
the enzyme employed in the Sequenase kit, is sensitive to the 
higher temperatures required to sequence a GC rich double 
stranded region. As a result, reliable sequence extension in 
these GC rich regions was difficult to obtain in regions 
greater than 200 nucleotides from the primer. Figure 9a shows 
a typical sequence "ladder" which results from situations such 
as this. Use of internal primers based on new sequence 
information usually allows further sequence determination, and 
sequence extension closer to these internal primers reduces 
premature termination due to secondary structure. However, in 
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this case the identification and use of internal sequencing 
primers was not possible due to the repetitive nature of the 
sequence beginning at position 128 (Figure 10). 
Due to the difficulties using the "Sequenase" method, all 
sequence obtained from position 160 to 300 (position numbering 
starts at EcoRI and moves to the left in Figure 3) was 
reconfirmed using the "Ampli-Taq" sequencing kit {Perkin-Elmer 
Cetus) • This kit employs Taq polymerase, a very stable enzyme 
at the higher temperatures (45-72°C) needed to reduce second-
ary structure in GC rich areas. Although ambiguous sequence 
was confirmed and some additional sequence was obtained, 
resolution was lost using this method at position 400. 
The majority of the EcoRI/PstI fragment was then isolated 
and subcloned as a 1.5 kb EcoRI/SmaI fragment (see Figures 3 
and 7) into the pGEM7Zf+ vector (p4. 6ME), so that nested 
deletion subclones could be generated for further sequencing. 
Creation of Nested Deletion Subclones 
The "Erase-A-Base" system {Promega Biotec) employs 
exonuclease III for the serial removal of nucleotides from the 
EcoRI digested end of p4.6ME. The extent of digestion is time 
dependent and allows the generation of a series of clones in 
which the 3' sequences are brought closer to the primer. This 
method allowed the generation of a series of clones containing 
overlapping sequences covering the remainder of the triple 
helical coding region (see Figure 7e). 
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Results Obtained with Sequencing Data Generated 
The nucleotide sequence and complete map. The deletion clones 
p4. 6ME-5, p4. 6ME-7 and p4. 6ME-9 {Figure 7e) were used the 
generate the remaining 435 nucleotides of sequence which 
extended 50 nucleotides beyond the most distal PvuII site (see 
Figure 3). This covered most, if not all, of the helical-
coding region homologous to Hf32. The entire 735 nucleotides 
of sequence generated by the above methods will be 
subsequently ref erred to as "NT7 3 5". The complete sequence 
{Figure 8) of NT735 confirms the presence of all restriction 
sites identified previously (Figure 3). Figure 9b includes a 
representative example of the acrylamide gels from which the 
sequence information was obtained. In contrast, Figure 9a 
shows the sequence "ladder" caused by premature termination 
of sequence extension due to secondary structure in GC rich 
regions. 
In addition to the site already identified by restriction 
mapping, two additional PvuII sites are present. That site 
most distal from EcoRI (farthest left), already determined by 
restriction digests, is at position 684, approximately 275 
nucleotides from the first site (closest to EcoRI). Another 
site is located equidistant between these two sites at 
position 408 (see Figure 3 and 8). The presence of this third 
site at position 408 explains why no 275 bp PvuII restriction 
fragment could be visualized in restriction digests. Upon 
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digestion, small fragments (approximately 137 bp each) are 
generated that are not resolved on a 1 or 1.2% agarose gel and 
also did not hybridize when restriction mapping and coding 
region localization were done. Also identified were the exact 
location of multiple AvaII restriction sites which had been 
previously difficult to determine due to their proximity to 
each other (see Figure 3 or 8). Sequencing data also revealed 
that single Sau96I (GGNCC) sites are always next to each of 
the PvuII sites (CAGCTG) in addition to the Ava II sites 
(GGA/TCC). As predicted, there are many (7) Sau96I sites in 
the helical-coding region of the EcoRI/PstI fragment. 
Basic organization. Analysis of the percentage of each of the 
four nucleotides within this sequence shows that the double 
stranded sequence contains 60% GC pairs. This GC richness is 
consistent with other collagen sequences (Bernard et al., 
1983). From position 128 to 721 there are at least 31 
uninterrupted direct repeats composed of the consensus 18 
nucleotide basic repeating unit, AAG ACC AGC AGC CCA GAC, each 
having a minimum of 83.4% identity to this sequence (Figure 
10). There are three brief interruptions. Each interruption 
is 9 nucleotides long and begins with a PvuII restriction site 
(indicated by carats and underlined in Figure 10). These 
interruptions are insertions which disrupt the direct repeats 
at these locations. However, their presence results in the 
coding of two perfect triple helical 9-mers with an amino acid 
sequence of (Gly-X-Y) 2 in the reverse translation at these 
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locations. There are also multiple thymidine insertions ("T"-
insertions) which interrupt the direct repeat at various 
locations in the NT735 sequence (see Figure 10). 
Although the basic repeating unit itself is not a strict 
triplet repeat sequence, a single nucleotide substitution, "C" 
for "A" in the fourth position, makes it so. Interestingly 
though, very few repeats contain this substitution. When it 
does occur, a "T"-insertion also occurs in that repeat making 
it 19 nucleotides long. For those repeats in which the "T" 
insertions occur subsequent to a PvuII site, two perfect 
triplet repeats adjacent to each other also occur. Again, 
these occur in the reverse translation. For example, position 
480 to 463 contains two Gly-X-Y 9-mers (refer to Figure 8 or 
10) • In addition, separated by a single nucleotide at position 
462, this occurs again from position 461 to 444. This occurs 
again at the second PvuII site and in the subsequent repeats 
with "T"-insertions. All of these perfect triplets occur in 
the reverse frames. However, because of the single nucleotide 
separating them, each pair of triplets occurs in a different 
reading frame. 
Higher order repeats. Higher order repeats in NT735 were 
identified with the aid of the GCG programs "Repeats" and 
"Find Patterns". In addition to the 18 nucleotide (nt) direct 
repeats this sequence also contains two 110 nt direct repeats 
with 93% identity from positions 148-256 and 257-366 with a 
single nucleotide insertion (Figure lla). It also contains 
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three 137 nt direct repeats at positions 291-429, 430-566, and 
567-703; each of which contains a PvuII site at homologous 
positions in the repeat {Figure llb). These repeats have 
between 92 and 99.27% similarity. No repeats longer than this 
were found. Noteworthy however, are four 54 nt repeats which 
were rejected because their identity {85%) was not signif-
icantly different from that of the 18 bp basic unit {83.4%). 
A repeat organization with higher similarity than the basic 
unit, such as that seen in the 110 and 137 nucleotide repeats, 
indicates that these sequences are more recently evolved than 
those of the early basic unit {Carnahan et al., 1993). 
The 18 nucleotide tandem, direct repeat and its higher 
order repeats are not necessarily a suprising finding 
considering that most collagen sequences contain a 9 
nucleotide triplet-coding basic unit. However, the "T"-
insertions and PvuII insertions are present at the same 
positions in each of the 137 nucleotide repeats, indicating 
that the insertions occurred prior to the larger repeat {137 
nt) duplication event involved in the evolution of these 
sequences. 
Protein translation. Using the GCG program routine "frames" 
{Figure 12), the analysis of the sequence translation 
indicates the presence of large open reading frames {greater 
than 200 nt's long) in the three reverse translation frames 
{D, E and F). In the forward translation several short open 
reading frames are confined to the first 300 nucleotides {100 
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amino acids) of the sequence (Figure 12). Open reading frames 
stop when an end codon is reached and only begin again if a 
methionine residue is encoded. Because the reverse frames 
contain the longer, and more collagen-like reading frames, the 
remainder of the sequence analysis results will focus on these 
frames unless otherwise stated. 
Amino acid composition. Although the 245 amino acid long 
protein translation (frame F is longest) does not represent 
a strict triple-helical coding sequence containing the {Gly-X-
Y) n repeat for more than two triplets and does not contain 
many lysine or proline residues, it does contain glycine at 
consistent and regular intervals of either every third, sixth 
or ninth codon in the reverse frames. All of the reverse 
frames contain patterns similar to this (Figure 13). The GCG 
program routine "Codon Frequency" was used to examine the 
protein translation in these frames. In addition to the 
abundance of glycine residues {16% maximum) all three frames 
contain nearly 22% of the non-polar residue leucine. The 
reverse translation frames also include high amounts of 
alanine (max. 13%), valine (9%) and tryptophan (9%). All are 
nonpolar residues which contribute to a high degree of 
hydrophobicity of a molecule. In addition to a 10% serine 
content, the polar disulfide bonding residue cysteine is 
present in an abundance equivalent to that of the non-
f ibrillar collagens (7.7%). Suprisingly, neither proline nor 
lysine are present in noteably high amounts, since these are 
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abundant in collagen sequences. 
The GCG program routine "Codon preference" is a frame-
specif ic gene finder that recognizes protein coding sequences 
by examining the specific codon frequency and GC bias or 
wobble in the translation of a sequence. Codon preference 
analysis suggests that the NT735 sequence contains expressed 
protein coding regions (Figure 14). In all frames the average 
codon preference is much higher (upper third of graph) than 
that of a random sequence. Although GC bias does not rank as 
high as codon preference, it is still clearly higher than 
would be seen for an untranslated or random sequence (bottom 
third of graph). These data indicate that the coding sequence 
of the reverse frames is likely to contain pref erred codons 
which occur in genes that are expressed. 
Nucleotide sequence comparisons. Nucleotide sequence 
comparisons to other human collagen sequences in the GCG 
GenEMBL database indicated that NT735 has the highest 
similarity to the 3' end of the cDNA sequence for human pro-
a2 (I) collagen (Locus=HUMCOLL) . The region of optimum identity 
or "bestfit" is that which includes triple-helical coding 
sequences of the probe, Hf32 (Figure 15). These results were 
expected since this was the probe used to isolate the clone. 
This collagen locus has nearly 52% identity to NT735 in a 690 
bp overlap (data not shown). The region of "bestfit" (position 
240 to 395 of NT735) within this region has 67.32% identity 
in a 175 bp overlap with four gaps. 
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Also having high sequence similarity to NT735 is the 3' 
end of pro-al(!) collagen, represented by the sequences of two 
cDNA clones, Hf404 & Hf677 (Locus=Humcglpal). With 52. 5% 
identity in 621 bp overlap, the "bestfit" region within this 
was 64.15% in a 122 bp overlap with 3 gaps (Figure 16). This 
region was contained within sequences of the cDNA clone Hf677. 
As expected, this probe, previously used as a negative control 
to confirm that our sequence was not a part of the al (I) 
collagen locus, has somewhat less sequence identity to NT735 
than the a2(I) locus. Although less similar than sequences of 
Hf32, it is not unexpected that this locus would also have 
high sequence similarity to NT735, since the two chains of 
Type I collagen are very similar to each other. 
The above sequence comparisons are consistent with the 
hybridization results obtained. Under the most stringent 
conditions used, the minimum similarity necessary for 
hybridization of Hf32 to occur is in the range of 65-75%. 
Since there is 67.32% identity between Hf32 and NT735 it is 
now clear why positive hybridization results were sometimes 
weak or inconsistent (data not shown). The conditions used 
approach the minimum similarity necessary for hybridization 
of the Hf32 probe to NT735. These ranges of similarity were 
determined by mathematical calculations of Tm values for 
reassociation in formamide (Mcconaghy et al., 1969). The upper 
value for the range is determined by including in the Tm 
calculation only the GC pairs in the two sequences. The lower 
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value was calculated by including the total GC content within 
NT735 in the region of similarity. It is however, difficult 
to assess the effect of gaps on hybrid stability and equally 
difficult to quantitate this effect. 
The minimum similarity necessary for hybridization of 
Hf677 to NT735 is in the range of 66.72-79.21%. This value is 
higher than the actual identity for these sequences (64.15%). 
According to these figures Hf677 should not hybridize to NT735 
under the conditions used, and in fact it did not. This 
confirms the accuracy of the negative hybridization results 
with this probe (see Figure lb). 
In the above collagen sequences examined the reverse 
strand of NT735 has the highest sequence similarities. This 
is consistent with the analysis of open reading frames (Figure 
12) indicating that the reverse frames contained long ORF's 
and codon preference data (Figure 14) suggesting these frames 
are likely to contain genuine protein coding sequences. 
Other Type I collagen sequences have lower sequence 
identity to NT735 than Hf32 sequences. For example, the 5' end 
of both al and a2 chains of Type I collagen showed nucleotide 
sequence identity over similar lengths; however, bestfit 
results indicated lower optimum identity, and in the case of 
a2(I), over much shorter lengths (data not shown). 
Other collagen types also have high sequence identity 
with overlaps of up to 550 bp (Table 1). These include the 
cDNA sequence of the chicken a2(I) collagen gene, and the 
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alternatively spliced transcripts of the Xenopus laevis al (II) 
collagen gene which contains many exons significantly larger 
than the 54 bp primordial unit. The genomic sequences of the 
intronless cuticle collagen gene of c. elegans have similarity 
to the forward strand as does the D. melanogaster collagen 
gene. The latter is also suggested to belong to the family of 
basement membrane or cuticle collagens, and contains large 
exons. Large coding regions such as these are characteristic 
of the non-fibrillar collagens. Since NT735 also contains 
large ORF's, this suggests it too has an organization similar 
to non-fibrillar collagens. 
In addition, the human Type XVI FACITs has nearly 75% 
identity in a 97 bp overlap and chicken Type XIV FACITs has 
54% identity over almost a 400 bp overlap {Table 1). Various 
short stretches of the Type XIV transcript approach 60% 
similarity when the bestf it is examined. Types IX (also a 
FACITs) and X collagen of various species also have 50-60% 
identity over short stretches. Much of the similarity to these 
non-f ibrillar collagen genes is in the forward strand of 
NT735. This is unexpected given that the Type I and II 
collagen similarities are in the reverse strands. The reverse 
frames of NT735 are those with the large, uninterrupted ORF's, 
a feature characteristic of the FACITs. 
Nucleotide sequence comparisons to the entire database 
showed the highest sequence identity in the forward strand is 
to the Wheat Glu-10-lb gene for HMW wheat glutenin subunit 5 
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(see Table 2). The sequence has as much as 67% identity over 
639 bp with 12 gaps. This is the highest identity with the 
longest region of similarity identified by the GCG program. 
This identity matches that of human a2(I) collagen but has 
many more gaps and a longer overlap. If the equivalent number 
of gaps as a2(I) collagen (4) are allowed, the identity to 
NT735 is still 50% over 557 bp. Many genes coding the subunits 
of this wheat seed storage protein have a nucleotide 
similarity of 55-65%, often over large (400-500) overlaps. 
Much of this similarity is in the central repetitive coding 
domain of the glutinen genes. The HMW subunits, such as 
subunit 5, are of particular importance in the glutinen 
molecule because the cysteine residues at their termini confer 
an unusual secondary structure contributing to its elastic 
properties. (Tatham et al., 1984). The above properties and 
its highly repetitive nature suggest that the wheat glutinen 
protein is the equivalent of human elastin, an ECM component 
which shares some characteristics of the fibrillar and non-
fibrillar collagens (Indik et al., 1990). 
Because the above information was relevant, an 
independent sequence comparison of NT735 to elastin coding 
sequences using the "Fasta" subroutine was done. This 
comparison indicated a 55% identity over 345 bp. A subsequent 
"bestfit" analysis indicated 63% similarity over 134 bp (1 
gap) to an exon which codes for a glycine rich, hydrophobic 
domain of the human elastin protein (Table 2). 
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Fasta comparisons of NT735 to the entire database also 
indicated high identity in the forward strand for the ~ 
virilis mastermind gene which codes for a large, highly 
repetitive nuclear protein required for normal CNS develop-
ment. The D. melanogaster mastermind gene had slightly lower 
identity. In both species the similarity lies in the region 
which contains the well characterized motifs called OPA 
repeats. OPA repeats are defined by a (CAX)n repeat, where X 
is an A or G, and n<31. These repeats are common to a variety 
of developmental regulator genes. Other genes which have 
noteworthy sequence similarity to NT735 are summarized in 
Table 2. Many of these genes code for very large proteins, 
contain long ORF's, and/or contain OPA or other homopolymeric 
repeats. The relative significance of these sequence similari-
ties will become more clear when the coding strand and reading 
frame of this new collagen-like sequence is determined. 
Amino acid sequence comparisons. The first approach to amino 
acid sequence comparisons employed the GCG routine "Tfasta" 
to examine the amino acid translations of the genes contained 
in the GenEMBL database. Consistent with the above results, 
HUMCOLL, the a2(I) locus of HF32, ranked highest in similarity 
in the protein translation frame F of NT735. However, the 
frame in which the similarity is seen is not the triple-
helical coding frame of the a2(I) chain. Many amino acids are 
not identical yet show similarity as "conservative replace-
ments". All of the human collagens with high nucleotide 
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sequence similarity which appeared in the peptide sequence 
comparison results showed amino acid similarity in frame D or 
F, but few genes were represented in the appropriate triple-
helical coding frame. The chick collagens showing similarity 
to frame D and F as well. 
The Herpes saimiri collagen-like protein mRNA sequence 
(Locus:HSVCLS) has 42.5% identity in a 40 amino acid overlap 
and 88% similarity when amino acids representing conservative 
replacements are included (Figure 17). This similarity is in 
the region of NT735, amino acid residues 140-180 of the 
reverse frame D, in which glycine occurs at every sixth 
residue. The glycine and tryptophan residues in both sequences 
are in homologous positions and the cysteine residues in NT735 
are always conservative replacements for serine residues. 
Though this information is interesting its significance is 
suspect because the protein translation of HSVCLS with this 
similarity is not the actual reading frame of this gene. 
However, upon examining the nucleotide sequence of this locus 
there is another interesting feature in common with NT735. In 
the region of similarity to NT735, HSVCLS contains an 18 
nucleotide repeat which spans its collagen-like open reading 
frame (Figure 17b). This repeat has 56% similarity to the 18 
nucleotide repeat of NT735. 
account for the identity 
This similarity is likely to 
seen between the amino acid 
translations discussed above. This is interesting because the 
HSVCLS locus is the only other known example (in addition to 
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NT735) of a collagen-like gene containing an 18 nucleotide 
basic repeat in its coding region. 
Various loci representing the HMW subunits of Wheat 
Glutenin also rank high in amino acid similarity in frames D 
thru F. For example, subunits 5 and 10 have as high as 46-57% 
identity over lengths of 30-40 amino acids in frames D thru 
F. Many of the regions of similarity are in the same consensus 
peptide and central domain sequences indicated in the 
nucleotide sequence comparisons (Table 2). These regions 
reside in a highly repetitive region of the molecule where the 
peptide sequence predicts a secondary structure with an 
abundance of a-turns. The cysteine residues located at the 
termini of these subunits, allow the close association of 
multiple glutinen monomers by intermolecular disulfide bonding 
(Forde et al. I 1985). The a-spiral structure predicted by 
these sequences and the abundance of terminal cysteine 
residues is suggested to confer elasticity to the wheat 
glutinen molecule much like that of human elastin (Tatham et 
al., 1984; Venkatachalam et al., 1981). 
The above amino acid sequence comparison results are in 
agreement with the nucleotide sequence comparison information. 
However, due to the technical limitations of the GCG "Tfasta" 
program the peptide translations of the genes identified are 
often not in the correct coding frame. This leaves their 
relationship to NT735 and a putitive peptide structure or 
function ambiguous at best. 
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In order to overcome the "Tfasta" routine limitations, 
the peptide database Swissprot was also examined using the GCG 
routine "Fasta". Each of the reverse frames of the amino acid 
translations of NT735 was compared to the swissprot peptide 
sequence database. The results of these comparisons were 
somewhat different from those above al though some common 
themes with regard to secondary structure exist. Nearly every 
peptide with similarity to the NT735 reverse translation 
frames was described as a membrane-associated molecule with 
a highly hydrophobic transmembrane region (see Table 3). It 
is these regions which show the highest similarity to NT735 
translations. These peptides included viral envelope 
glycoproteins, surface antigens and receptors, channel 
proteins, and structural glycoproteins with carbohydrate 
attatchment sites. Many of these regions with identity cross 
the cell membrane multiple times serving as an anchor for 
large intra- and extra- cellular chains with diverse inter-
active properties. Table 3 summarizes the key features of some 
these proteins in an attempt to understand the basic features 
of the peptide encoded by NT735. Those listed in the table 
have at least 20% identity over a minimum of 20 amino acids, 
as has often been reported in other work (Trueb and Trueb, 
1992) • 
Because the swissprot database search was so informative 
with regard to the consistent nature of the proteins 
identified (and of course, in the correct coding frames) , 
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independent protein comparisons were done for both elastin, 
mentioned earlier in conjunction with wheat glutinen, and the 
HSVCLS protein. No further informative results were obtained 
for HSVCLS. However, Swissprot comparisons of NT735 to elastin 
proved informative. For a number of species, including 
humans, the range of identity was 39 to 53%, with an overlap 
of 17 to 30 amino acids. Although this is not a very long 
overlap, a 30 amino acid length is comparable to some of those 
proteins listed in Table 3. 
Although the specific functional domains of the putative 
peptide of NT735 are not yet clear, most of the nucleotide and 
amino acid similarities to other protein coding genes lie in 
the region of the 18 bp direct repeat. Few matches were seen 
in amino acids 200 thru 245 (reverse frames) which represents 
the non-repetitive portion of the nucleotide sequence. 
Furthermore, much of the similarity identified in the 
"Swissprot" comparisons is to the left of the first Ava II 
site (see Figure 3) at nucleotide position 230 (see Figure 8). 
Consistent with the initial hybridization studies this site 
was identified as the beginning of the helical coding region 
for the gene. Although the exact endpoint of the coding region 
is still not clear, most of the amino acid similarity appears 
confined to the sequence prior to last Pvu II site (nucleotide 
position 680). This general pattern is consistent with all my 
experimental results and the sequence comparison data 
presented. 
57 
Figure 1. Characterization of chromosome 17 phage clones. 
A pro-a2 (I) cDNA clone (Hf32) was used to screen a human 
chromosome 17 library containing HindIII fragments in lambda 
phage Charon 21A. Five independent positive phage isolates 
were digested with HindIII to excise the inserts which were 
then hybridized with: A- Pro-a2(I) cDNA (Hf32); B- Pro-al(I) 
cDNA (Hf677); c- Alu repetitive sequence (Blur 8). Some 
isolates are present in multiple lanes because several 
individual plaques from the same original isolate had been 
chosen for analysis. 
Lane 1 & 2, Isolate #1 
Lane 3, Isolate #2 
Lane 4, Isolate #3 
Lane 5 & 6, Isolate #4 
Lane 7 & 8, Isolate #5. 




















Figure 2. Confirmation of successful cloning of target 
fragment. DNA from normal placenta (Lanes 1 & 3) and OI Type 
III patient blood (Lanes 2 & 4) was digested with HindIII 
(Lanes 1 and 2) or PstI (Lanes 3 & 4) and hybridized to the 
phage clone (isolate #1). A- hybridization stringency was low 
(2xSSC, 50°C). B- stringency was high (O.lxSSC, 65°C). 
Selected fragment sizes in kb are indicated. 
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Figure 3. Restriction map of the 4.6 kb cloned fragment. 
The new collagen locus on chromosome 17 was cloned from a 
chromosome specific phage library as a 4.6 kb HindIII 
restriction fragment. Restriction sites for the indicated 
enzymes are shown on superimposable lines representing the 
same HindIII fragment. The locus contains a short triple 
helical coding region that cross-hybridizes to the pro-a2(I) 
cDNA, Hf32 (black box) . Fragment sizes in base pairs are 
indicated. The locations of Alu repetitive sequences are also 
indicated(*). Not all restriction sites are shown. 
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Figure 4. Restriction mapping of p4.6 and localization of 
triple helical coding region. 
A- Restriction digests of p4.6 were hybridized to the pro-
a2(I) cDNA probe Hf32. 
Lane 1, HindIII+PstI Lane 6, BamHI 
Lane 2, HindIII Lane 7, HindIII+Bam HI 
Lane 3, HindIII+XbaI Lane 8, HindIII+BamHI+SstI 
Lane 41 EcoRI+PstI Lane 9, HindIII+SstI 
Lane 5, EcoRI+BamHI Lane 10, HindIII+SmaI 
Selected fragment sizes in kb are indicated. The fragment 
containing triple helical coding sequences is represented by 
the 1. 6 kb EcoRI/PstI band seen in lane 4. The strongly 
hybridizing 2. 7 kb fragment is the plasmid vector. Lanes 
indicated by underlining represent the pertinent data as 
discussed in the text. 
B- Restriction digests of p4.6 were hybridized to the pro-
a2 (I) cDNA probe Hf32. 
Lane 1, AvaII+BamHI Lane 6, PvuII+HindIII 
Lane 2, AvaII+EcoRI Lane 71 PvuII+PstI 
Lane 3, Aval! Lane 8, PvuII 
Lane 4, AvaII+SstI Lane 9, PvuII+SstI 
Lane 51 AvaII+HindIII 
Selected fragment sizes in kb are indicated. Hybridation to 
a single (vector) fragment in Lane 6 indicates no hybrid-
ization to the upper (1.4 kb) HindIII/AvaII fragment of the 
doublet at this position. There is also no hybridization to 
an 800 bp PvuII/PstI subfragment of HindIII/ Aval I. These 
fragments span the PstI end of the triple helical coding 
fragment (see restriction map). Lanes indicated by under-
lining represent the pertinent data as discussed in the text. 
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Figure 5. Southern blot representing Sau96I restriction 
digests of p4.6 hybridized with the pro-a2{I) probe Hf32. 
Lane 1, p4.6 DNA digested with HindIII, EcoRI and Sau96I 
Lane 2, pUC13 DNA digested with HindIII, EcoRI and Sau96I 
Lane 3, p4.6 DNA digested with EcoRI, PstI and Sau96I 
Lane 4, pUC13 DNA digested with EcoRI, PstI and Sau96I 
Only vector sequences (pUC13 DNA) in fragments greater than 
200 bp are detected by the probe. Fragments representing 
insert sequences only are digested by Sau96I into fragments 
of less than 200 bp. Sizes in bp are indicated. 
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Figure 6. Localization of Alu repetitive sequences in p4.6. 
Restriction digests of p4.6 were hybridized to the Alu probe, 
Blur 8. 
Lane 1, HindIII+PstI Lane 6, HindIII+SstI+BamHI 
Lane 2 I EcoRI+PstI Lane 7, HindIII+SmaI 
Lane 3, EcoRI+BamHI Lane 8, EcoRI+SmaI 
Lane 4, BamHI Lane 9, PstI+SmaI 
Lane 5, HindIII+BamHI 
The 1600 bp EcoRI/PstI and the 800 bp HindIII/SstI hybridize 
strongly to Blur 8. The 700 bp HindIII/PstI band hybridizes, 
although more weakly. Another Southern blot confirmed that 
the Alu sequence in the 1600 bp fragment was confined to the 
850 bp adjacent to the PstI end of that fragment (data not 
shown). Lanes indicated by underlining represent the 
pertinent data as discussed in the text. Vector sequence 
hybridization and larger fragments which were uninformative 
are not shown. 
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Figure 7. Schematic diagram of the clones and subclones used 
to characterize the collagen-like locus. Only a portion of 
the vectors are shown in the diagrams. A- The original Charon 
21A phage isolate containing the 4.6 kb HindIII insert. B-
p4.6, the pUC13 vector containing the 4.6 kb HindIII insert. 
c- p4.6EP, the pUC13 vector containing the 1.6 kb EcoRI/PstI 
triple helical coding fragment. D- p4. 6ME, the pGEM7Zf+ 
vector containing the 1.5 kb EcoRI/SmaI triple helical coding 
fragment. E- Linearized p4. 6ME and the resulting nested 
deletion subclones generated by the "Erase-A-Base" system. 
These deleted subclones were recircularized prior to 
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1 GAATTCCAGT CACTCCCTCC AGGAGACACA CCAGCAGTGG TCAGGAAGCA 
51 AGTCCACCAC AGCCTTCTGG AAAGGTCTCT AGTCTCAGGA GACACGAGCC 
Sau96I 
101 ACTCAAGCCT CCCACATGCC ACCAAAGAAG ATAAGCTGGC CCAGAGAAGA 
151 CCAGCAGCCC AGAGAAGACC AGCAGCCTGG ACAAGACCAA CAGCCCAGAC 
Ava II Aval! 
201 ATAGACCAGC AGCCCAGAAA GGACCAGCAG CCCAGACAGG ACCAGCAGCC 
251 CAGGCAAGAC CAGCAGCCTG GACAAGACCA GCAGCCTGGA CAAGACCAAC 
Aval! 
301 AGCCCAGACA TAGACCAGCA GCCCAGACAG GACCAACAGC CCAGACATAG 
Ava II 
351 ACCAGCAGCC CAGACAGGAC CAGCAGCCCA GACAAGACCA GCAGCCTGGA 
PvuII 
401 CAAGAACAGC TGGCCCAGCA GCCCATACAA GACCAGCAGC CCAGATATAG 
451 CCCAGCAGCC CAGACATAGC CCAGCAGCCC AGACAAGACC AGCAGCCCAG 
PvuII 
501 ACAAGACCAG CAGCCTGGAC AAGACCAGCA GCCAGGATAA GAACAGCTGG 
551 CCCAGCAGCC CATACAAGAC CAGCAGCCCA GATATAGCCC AGCAGCCCAG 
601 ACATAGCCCA GCAGCCCAGA CAAGACCAGC AGCCCAGACA AGACCAGCAG 
PvuII 
651 CCCGGACAAG ACCAGCAGCC AGGATAAGAA CAGCTGGCCC AGCAGCCCAT 
701 ACAAGACCAG CAGCCCAGAC ATAGCCCAGC AGCCC 
Figure 8. The complete nucleotide sequence of NT735. Selected 
restriction sites are indicated above their recognition 
sequence. Numbers on the left margin indicate the nucleotide 
position at the start of the line. A space is inserted after 
every tenth nucleotide for easier reading. 
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Figure 9. 8% Acrylamide sequencing gels. A- An unreadable 
sequencing gel generated by the "Sequenase" kit. This 
illustrates a typical repeating "ladder" pattern resulting 
from premature termination due to GC richness and 2° structure 
of the template DNA. This is roughly the same region shown in 
B. B- A gel from which 108 nucleotides can be read as 
pictured here (position 324 to 432 of the NT735 sequence). 
This sequence was generated using the "Ampli-Taq" kit. The 
AvaII sites at positions 339 and 366 respectively are 
indicated. The letters at the top indicate the nucleotide 
represented in the corresponding lane. 
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A- B-




Figure 10. Sequence of NT735 aligned to illustrate the 18 
nucleotide direct repeats. There are at least 31 repeats with 
a minimum of 83.4% identity to the basic repeat and 3 brief 
insertions of 9 nucleotides each. Single thymidine insertions 
also occur periodically. The carats indicate the exact 
location of the insertions which have been removed and placed 
above the sequence that they interrupt. Bold nucleotides 
indicate changes from the basic repeat unit. Numbers to the 
left indicate the respective repeat. Numbers to the right 




















































































1 8 2 
2 1 9 
2 5 5 
3 0 9 
3 4 6 
3 8 3 
4 2 8 
4 8 4 
5 6 5 
6 2 1 
6 7 5 
7 3 5 
72 
5 0 
1 0 0 
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A-
148 AGACCAGCAGCCCAGAGAAGACCAGCAGCCTGGACAAGACCAACAGCCCA 197 
111111111111 II 111111111111111111111111111111111 
111111111111 II 111111111111111111111111111111111 
257 AGACCAGCAGCCTGGACAAGACCAGCAGCCTGGACAAGACCAACAGCCCA 306 
. * 
198 GACATAGACCAGCAGCCCAGAAAGGACCAGCAGCCCAGACA.GGACCAGC 246 
111111111111111111111 1111111 11111111111 1111111 
111111111111111111111 1111111 11111111111 1111111 
307 GACATAGACCAGCAGCCCAGACAGGACCAACAGCCCAGACATAGACCAGC 356 
247 AGCCCAGGCA 256-......__ 
II I I I II II /3% 
1111111 II 
357 AGCCCAGACA 366 
----------------------------------
B-
291 AGACCAACAGCCCAGACATAGACCAGCAGCCCAGACA.GGACCAACAGCC 339 
1111111111111111 1111 111111111111111 I Ill 11111 
1111111111111111 1111 111111111111111 I Ill 11111 
430 AGACCAGCAGCCCAGATATAGCCCAGCAGCCCAGACATAGCCCAGCAGCC 479 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
567 AGACCAGCAGCCCAGATATAGCCCAGCAGCCCAGACATAGCCCAGCAGCC 616 
340 CAGAC~ACCAGCAGCCCAGACAGGACCAGCAGCCCAGACAAGACCAGC 391 
111111111111111111111111 11111111111 111111111111 
111111111111111111111111 11111111111 111111111111 
480 CAGACAAGACCAGCAGCCCAGACAAGACCAGCAGCCTGGACAAGACCAGC 529 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
617 CAGACAAGACCAGCAGCCCAGACAAGACCAGCAGCCCGGACAAGACCAGC 666 
PvuII. 
392 AGCCTGGACAAGAACAGCTGGCCCAGCAGCCCATACA 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
530 AGCCAGGATAAGAACAGCTGGCCCAGCAGCCCATACA 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
667 AGCCAGGATAAGAACAGCTGGCCCAGCAGCCCATACA 
429~ 




Figure 11. Higher order repeats of NT735. A- Two 110 
nucleotide direct repeats. B- Three 137 nucleotide direct 
repeats. Dashed vertical lines indicate nucleotide identity. 
Whole numbers indicate nucleotide position numbers. 
Percentages represent identity between repeats as indicated. 
Insertions are indicated by an asterisk (*) in A, or carat 

















Figure 12. Schematic diagram of the open reading frames of the translated sequence of NT735. 
Open boxes indicate the open reading frames. Solid lines represent regions which are not 
open reading frames. Letters to the left indicate the frame, with frame A beginning with 
nucleotide number 1 and frame F beginning with nucleotide number 735. Numbers on the bottom 




Translation frame "F" 
1 GLLGYVWAAG LVWAAGPAVL ILAAGLVRAA GLVWAAGLVW AAGLCLGCWA 
51 ISGLLVLYGL LGQLFLSWLL VLSRLLVLSG LLVLSGLLGY VWAAGLYLGC 
101 WSCMGCWASC SCPGCWSCLG CWSCLGCWSM SGLLVLSGLL VYVWAVGLVQ 
151 AAGLVQAAGL AWAAGPVWAA GPFWAAGLCL GCWSCPGCWS SLGCWSSLGQ 
201 LIFFGGMWEA *VARVS*D*R PFQKAVVDLL PDHCWCVSWR E*LEF 
Translation frame "E" 
1 GCWAMSGLLV LYGLLGQLFL SWLLVLSGLL VLSGLLVLSG LLGYVWAAGL 
51 YLGCWSCMGC WASCSYPGCW SCPGCWSCLG CWSCLGCWAM SGLLGYIWAA 
101 GLVWAAGPAV LVQAAGLVWA AGPVWAAGLC LGCWSCLGCW SMSGLLVLSR 
151 LLVLSRLLVL PGLLVLSGLL VLSGLLVYVW AVGLVQAAGL LWAAGLLWAS 
201 LSSLVACGRL EWLVSPETRD LSRRLWWTCF LTTAGVSPGG SOWN 
Translation frame "D" 
1 AAGLCLGCWS CMGCWASCSY PGCWSCPGCW SCLGCWSCLG CWAMSGLLGY 
51 IWAAGLVWAA GPAVLILAAG LVQAAGLVWA AGLVWAAGLC LGCWAISGLL 
101 VLYGLLGQLF LSRLLVLSGL LVLSGLLVYV WAVGPVWAAG LCLGCWSCPG 
151 CWSCPGCWSC LGCWSCLGCW SFLGCWSMSG LLVLSRLLVF SGLLVFSGPA 
201 YLLWWHVGGL SGSCLLRLET FPEGCGGLAS *PLLVCLLEG VTGI 
Figure 13. Amino acid sequence translations of the reverse 
frames of NT7 3 5. A space is inserted after every tenth 
residue to facilitate readability. Some glycine residues are 
highlighted in bold in order to demonstrate the regular 
interval pattern in which they occur. Asterisks {*) indicate 
the presence of a "stop" codon. 
76 
Figure 14. Codon preference data for reverse translation 
frames of NT735 (D, E and F). The letters on the left 
indicate the reading frame represented by the corresponding 
graph. The numbers on the top and bottom of the figure 
indicate approximate nucleotide positions. The solid line 
represents codon preference. The dashed line represents GC 
bias. The Y-axis is split in three sections. A curve lying in 
the upper region (1. 2-2. 0) indicates a strong pattern of 
codon choices similar to that of expressed genes. One lying 
in the lower region indicates no pattern of similarity to 
expressed genes (0-0. 75). The middle region represents a 
pattern which cannot be accurately assessed based on the 
information available. Nearly all codon preference curve lies 
in the upper third of the graph. Much of the GC bias curve 
lies in the upper two-thirds of the graph; sometimes in the 
upper third coinciding with codon preference in select 
regions of the sequence. This data indicates that the coding 
sequence in the reverse frames is likely to contain pref erred 
codons which occur in genes which are expressed. The boxes 
beneath each graph correspond to the open reading frame and 
the small vertical ticks below them represent the occurance 
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NT735 x Humcoll 
DEFINITION: Human collagen pro-a2(I) chain mRNA. 
Percent Identity: 67.320 Length: 175 Gaps: 4 
78 
395 GCTGCTGGTCTTGTCTGGGCTGCTGGTCCTGTCTGGGCTGCTGGT ••••. 351 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
164 GCTCATGGTGCTGTAGGTGCCCCTGGTCCTGCTGGAGCCACAGGTGACCG 213 
350 ... CTATGTCTGGGCTGTTGGTCCTGTCTGGGCTGCTGGTCTATGTCTGG 304 
I I I 111111 11111111 I 111111111 II II 
I I I I I I I I I I I I I I I I I I I I I II I I I I II I I 
214 GGGCGAAGCTGGGGCTGCTGGTCCTGCTGGTCCTGCTGGTC ..• CTCGGG 260 
303 G •.... CTGTTGGTCTTGTCCAGG •...•• CTGCTGGTCTTGTCCAGGCT 265 
I I I I I I I I I I I I I I I II I I I I I I 
I I II I I I I I I I I I I I I I I I I I I I 
261 GAAGCCCTGGTGAACGTGGCGAGGTCGGTCCTGCTGGCCCCAACGGATTT 310 
264 GCTGGTCTTGCCTGGGCTGCTGGTC 240 
I I I I I I I I I I I I I I I I I I I I 
II I I I I I I I I I I I I I I I I I I 
311 GCTGGTCCGGCTGGTGCTGCTGGTC 335 
Figure 15. GCG "bestfit" comparisons of NT735 (top) to the 
Hf32 (bottom) region of HUMCOLL locus. Dashed vertical lines 
indicate nucleotide identity. Whole numbers indicate 
nucleotide position. Dots are placed at every tenth position 
above the sequence. 
NT7315 z Humcglpal 
DEFINITION: Human pro-al(I) chain of type I collagen mRNA. 
Percent Identity: 64.151 Length: 122 Gaps: 3 
79 
342 GGGCTGTTGGTCCTGTCTGGGCTGCTGGTCTATGTCTGGGCTGTTGGTCT 293 
I I I I • I I I I I I • I I I I I I I I I I I I I I I 
I I I I • I I I I I I • I I I I I I I I I I I I I I I 
1865 GTGCTCNTGGTGCTCNTGGTGCCCCTGGCC •••.....•• CCGTTGGCCC 1904 
292 TGT .•. CCAGGCTGCTGGTCTTGTCCAGGCTGCTGGTCTTGCCTGGGCTG 246 
I I I I I I I I I I I I I I I I I I I I I I I I I I I 
I I I I I I I I I I I I I I I I I I I I I I I I I I I 
1905TGCTGGCAAGAGTGGTGATCGTGGTGAG ... ACTGGTCCTGCTGGTCCCG1951 
245 CTGGTCCTGTCTGGGCTGCTGG 224 
I I I I I I I I I I I I I I I I 
I I I I I I I I I I I I I I I I 
1952 CCGGTCCCGTCGGCCCCGCTGG 1973 
Figure 16. GCG "bestfit" comparison between NT735 (top) and 
Hf677 region of Humcglpal locus. Dashed vertical lines 
indicate nucleotide identity. Whole numbers indicate 
nucleotide position. Dots are placed at every tenth position 
above the sequence. 
A-
DEFINITION Herpesvirus saimiri collagen-like protein 
ACCESSION M3 l 964 
KEYWORDS collagen-like protein 
42.5% identity in 40 aa overlap 
88% similarity over 40 aa overlap 
120 130 140 150 160 
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Nt735dLLVLSGLLVLSGLLVYVWAVGPVWAAGLCLGCWSCPGCWSCPGCWSCLGCWSC 
1 ••• 11.1 •• 1.1 •• 1.1 •• 11.1 •• 
1•• •11•1•• ,., •• 1•1••11•1•• 
HsvclsXNYDSKQXVCYKQSWQSXRSWRSWGSWRSLGSWRSLGSWRSLGSWRSLGSWRS 
440 450 460 470 480 
170 180 190 200 
Nt735dLGCWSFLGCWSMSGLLVLSRLLVFSGLLVFSGPAYLLWWHVGGLSGSCLLRLE 
I I • I • I I • I 
I I • I • I I • I 
HsvclsLGSWRSLGSWRSWRSLRSSISCFFSWISXVWLACHFLSSVFVLLLLAVSCVTL 
490 500 510 520 530 
B-
NT735 ACAAGACCAGCAGCCCAG 
I 1111 I 1111 
I 1111 I 1111 
HSVCLS GGACCTCCAGGACCCCAA 
Figure 17. Sequence comparisons between NT735 and the 
collagen-like sequences of H. saimiri virus. A- Amino acid 
sequence comparison results from the GCG "Tfasta" subroutine. 
Dashed vertical lines (I) indicate identity. Double dot 
vertical lines (:) indicate that the residues have similarity 
as conservative replacements. Whole numbers indicate amino 
acid position. B- Nucleotide sequence comparison between the 
18 nucleotide repeats of NT735 and H. saimiri. Dashed 














I Type II fibril 
81 
Figure 18. Schematic diagrams of the domains of the Type IX 
collagen molecule (A) and its alignment on the surface of the 
Type II fibril in cartilage (B) . At the hinge region the COL3 
and NC4 domains project into the matrix, while the GAG side 
chain associates in the gap region of the fibril. Reproduced 
from Biomaterials Vol. 11, p. 30 (van der Rest et al., 1990). 
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Table 1. Collagen genes with nucleotide similarity to NT735. 
This table summarizes those collagen genes identified with 
the GCG fasta program having 50% or greater similarity to 
NT735. Genes with less than a 100 nucleotide overlap are not 
included. The column labelled "Strand" indicates whether the 
similarity is in the forward {/for) or reverse {/rev) strand 
of NT735. In the "GAPS" column an asterisk {*) indicates a 
"fasta" comparison result, therefore no significant gaps are 
present. Fasta comparisons optimize the length of overlap 
and minimize gaps to only a few nucleotides, whereas 
"bestfit" comparisons optimize identity by finding that 
portion of the sequence with highest identity {forfeiting 
overlap length and inserting gaps). When two bestfit 
identities are reported for the same gene, they represent the 
same region of comparison with a different number of gaps 
allowed. 
CENE TYPE LOCUS STRAND %IDENTITY 
Human HUM COLL /rev 67.32 
Collagens 52.0 
HUMCG1PA1 /rev 6Ll.15 
52.5 
HUMCOL16A /for 67.6 
7Ll.6 
Other couagens CELCOL /for 5LI 
63 
CHKCOL /rev 5LI 
XELCOL2A1 /rev 53 
DROCOL /for 59 
56 
CHKCOL 1LIA1 /for 5LI 
Type x collagen /for 50·60 



















a2(1) Collagen LOCUS 
Of Hf32 




c. Elegans cuticle 
collagen 
Chicken a2m collagen 
X. Laevls a1UO 
collagen 
Drosophila cuticle or 
B.M. collagen gene 







Table 2. Non-collagen genes with nucleotide similarity to 
NT735. This table summarizes the nucleotide sequence compari-
son results for those non-collagen loci with high sequence 
similarity over long (>200 nt) stretches. The column labelled 
"STRAND" indicates whether the similarity is in the forward 
(/for) or reverse (/rev) strand of NT735. In the "gap" column 
an asterick (*) indicates a "fasta" comparison result, 
therefore no significant gaps are present. Fasta comparisons 
optimize the length of overlap and minimize gaps to only a 
few nucleotides, whereas "bestfit" comparisons optimize 
identity by finding that portion of the sequence with highest 
identity (forfeiting overlap length and inserting gaps). The 
column labelled "OPA" indicates if the gene does (Y=Yes) or 
does not (N=No) contain OPA repeats. 
GENE LOCUS STRAND %ID OVERLAP 
Wheat WHTGL1018 /for 66.6 639 
Glutinen 60 557 
Human HSELASRNA /rev 54.8 345 
Elastin 63.2 134 
OroSOQhila ORO MAS /for 67.7 196 
Mastermind 
Mouse OPA MUSOPA /for 60.9 417 
orosoQhila DROP ROS /for 60 225 
Prospero 
DrosOQhila FSH DROFSH /for 53.7 566 















Human elastin gene 
-Hydrophobic exon 
OPA repeat of 
o.virilis Mastermind 
gene 























Table 3. Summary of proteins with similarity to the NT735 
reverse translations. Comparisons were done using the 
"Swissprot" database. The region of similarity in the peptide 
translation of NT735 is indicated by frame and amino acid 
position. comments regarding structural features of the 
identified proteins are limited to the regions with identity. 
PROTEIN Region Of slmllartty 
within NT7:S5 translation 
<amino acid position> 
Latent membrane protein of 10-40 
Epstein-Barr virus 
Kell G-proteln 25-45 
Uukunleml virus membrane 30-95 
glycoprotelns G1 and G2 
Rat heart Na+ channel lsoform 40-80 
Chicken Elastln 150-180 
Hepatitis c virus <HCV> envelope 135-185 
protein 
X.laevls cystic fibrosis 175-215 
tranductance regulator 
Large regions of overlap: 
Latent membrane protein of 66-208 
Epstein Barr virus 















Viral membrane protein 
-Leuclne rich 
corresponds to exact 
transmembrane region <30-45> of Kell 
-same as In VGLM 
A.K.A. VGLM 
Viral llpo-membrane region adjacent 
to G2 
-Hydrophobic 




Clustered glycosvlatlon sites 
-Hydrophobic 
overlaps two transmembrane 
regions and spans Junction 
Spans membrane five times! 
<25% ID, 52% Slmllarltv> 
Nearly entire Surface Ag chain! 




This work involves the isolation and characterization of 
a new human collagen-like locus associated with osteogenesis 
imperfecta. The locus, represented by a 4. 6 kb HindIII 
fragment, is located on chromosome 17 (Cammarata et al. , 
1991) . The goal in this study was to isolate the 4. 6 kb 
HindIII fragment and characterize the triple helical coding 
region within it. Restriction mapping and sequencing was the 
approach chosen as a first step to understanding what 
molecular organization might contribute to the deletions seen 
in OI patients at this site. Determining the detailed 
molecular organization of this locus is also the necessary 
initial step in characterizing the structure, and ultimately 
the function, of the putative protein for which the new locus 
codes. 
Identification of Cloned Seguences 
The initial hybridization studies (Figure 1) confirmed 
that sequences within this locus have similarity to triple 
helical coding regions of the COL1A2 gene. These sequences 
are distinct from those of the COLlAl gene, which also 
resides on chromosome 17. Since there are no other reported 
88 
89 
collagen genes on chromosome 17 (Byers, 1989), this locus 
clearly contains sequences of a new human collagen-like 
locus. These studies also demonstrate that the clone, p4.6, 
is more similar to helical coding sequences of COL1A2, than 
COLlAl. This information was later confirmed through direct 
sequence analysis. 
Hybridization of the clone back to human genomic DNA 
confirmed that this locus does, in fact, represent the 
deletion-prone fragment previously shown to be associated 
with the OI phenotype (Figure 2). 
Repeat Organization and Deletion Mechanisms 
Although the presence of Alu direct repeat family 
sequences is not unusual in collagen genes (Barsh et al., 
1981; Chu et al., 1984; Sandell and Boyd, 1990), their 
exceptionally high density in regions adjacent to the helical 
coding sequences of this new locus is noteworthy. Many 
instances have been described where Alu-Alu recombination has 
caused clinical pathologies due to the deletion of coding 
information (Lehrman et al., 1987, Markert et al., 1988). The 
evolutionary divergence of two related genes due to 
homologous recombination at Alu repeats has also been 
suggested (Kudo et al., 1989). Both intra- and inter-
chromosomal unequal recombination and interchromatid unequal 
recombination have been suggested to contribute to 
polymorphisms seen at Alu sites (Vnencak-Jones et al., 1988). 
90 
Repetitive sequences with relatively short basic repeat 
units (2-25 nucleotides) can also be responsible for 
deletions which lead to length polymorphisms. There are 
reports of a region adjacent to the COL2Al gene which 
exhibits a high degree of length polymorphism due to the 
variation in the number of copies of a simple tandemly 
repeating dinucleotide sequence. 
are adjacent to COL2Al are 
The tandem repeats which 
suggested to cause the 
polymorphisms via a mechanism known as "slipped-strand 
mispairing" (Tiller et al., 1990; Sykes et al., 1985; Stoker 
et al., 1985). such a mechanism can cause the looping out 
and excision of intervening DNA when one direct repeat 
misaligns with another during DNA replication. (Richards et 
al., 1992; Efstratiadis et al., 1980). This same event also 
occurs in some cases of Alu-Alu recombination except that the 
Alu repeats reside in the introns of a gene and the 
intervening or excised coding DNA does not necessarily 
contain a directly repeating motif (Lehrman et al., 1987). 
The organization of the 18 nucleotide tandem repeat of 
NT735 is much like that of the direct repeats which cause 
polymorphisms seen in other collagen and non-collagen genes 
(Stoker et al., 1985; Richards et al., 1992; Zuliani et al., 
1990). Since there is high identity between the repeats of 
NT735, and they extend for at least 600 base pairs, 
misalignment during DNA replication not only seems possible, 
but highly probable. It is therefore likely that this direct 
repeat organization is the cause of the length variations 
91 
seen at the Site 2 locus. 
Recent studies in our lab have, in fact, mapped the 
deletion site in an OI Type III patient to the EcoRI/PvuII 
restriction fragment in the sequenced region containing the 
direct repeats (Michaels, unpublished). Future studies 
analyzing the molecular structure of this region in affected 
individuals will clarify the endpoints of those deletions 
which are, in fact, associated with the Type III OI 
phenotype. 
Although the possibility may exist, the information obtained 
to this point is not consistent with the involvement of the 
Alu repeats as a cause of the deletions at this site. 
The detection of 4.6 kb and 4.3 kb alleles of a normal 
individual, in addition to the single 4.4 kb deletion 
fragment of a homozygous, CI-affected individual (Figure 2) 
indicates that not all deletions at Site 2 result in an 
obvious OI phenotype. It is possible that individuals 
heterozygous for small deletions may be less affected, if at 
all, than individuals who are either heterozygous for larger 
deletions or homozygous for deletions at this locus. The 
specific location and/or extent of the deletion within Site 
2 could also play a role in the expression of the OI 
phenotype. 
Slipped-strand mispairing can also result in the 
duplication or amplification of repeated sequences. The 
amplification of direct repeats has been associated with 
other heritable disorders such as fragile X syndrome and 
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myotonic dystrophy (Caskey et al., 1992). In these disorders 
premutation alleles contain triplet-repeat sequences which, 
when amplified beyond a crucial threshold number, result in 
events that cause the expression of the disease (Caskey et 
al., 1992). Due to the same molecular mechanism (slipped-
strand mispairing), the sequence amplification that results 
in these pathologies is the direct complement to the 
deletion-caused condition in p4.6 associated with Type III 
OI. 
Not only can the slipped-strand mispairing mechanism 
contribute to detrimental events resulting from duplication 
or deletion but it can also serve a function in the evolution 
of repetitive sequence families and gene families which 
contain repetitive motifs (Levinson and Gutman, 1987; Kudo et 
al., 1989; Saitta et al., 1991). The structure of the higher 
order repeats in NT735 suggests that tandem duplication 
events are likely the mode of evolution in this gene. The 
nature of those duplications can be assessed by examining the 
relationship between similar repeats. Generally, those 
repeats with higher identity to each other are more closely 
related and more recently amplified than their counterparts 
of lesser identity (Carnahan et al., 1993). For example, in 
Figure llb, the 137 nucleotide higher order repeats which 
occur at a location represented by nucleotide positions 291-
429 and 430-566 have 92% identity, whereas the later repeats, 
positions 430-566 and 567-703 have 99% identity. This repeat 
organization indicates that the last two repeats, with 99% 
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identity, are more recently amplified than repeats earlier in 
the sequence. Thus, based on the extent of the identity 
between repeats, the likely evolutionary order of these 
sequences is from the 18 nt repeats (approximately 84% 
identity), to the more recent 110 nt (93% identity) 
intermediate. Finally, the 137 nt repeats with the highest 
identity (99%) must be most recently evolved. 
An Expressed Collagen-Like Gene 
From the hybridizations (Figures 1 and 4) and nucleotide 
sequence translations (Figure 13) it is clear that the Site 
2 locus contains a collagen-like sequence with a repetitive 
motif. The level of GC richness (60%) seen in the NT735 
sequence is similar to that of other collagen and connective 
tissue (ECM) genes. Analysis of potential open reading 
frames, codon preference, and GC bias (Figures 12 and 14) 
suggests that the reverse translation frames contain coding 
information likely to occur in a gene that is expressed. 
Recently, Northern blot and dot blot hybridizations of total 
RNA from normal human fibroblasts to p4. 6 sequences confirmed 
that this locus is, in fact, transcribed (Breslin, 
unpublished) • Future studies will determine the correct 
reading frame and the exact regions that are transcribed. 
Abnormal Type I collagen incorporated into fibrils has 
a drastic effect on tissue integrity, resulting in the OI 
phenotype (Prockop et al., 1989). Since the Site 2 collagen-
like gene is associated with the OI phenotype (Doering et 
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al., 1987), it is likely that defects in its protein product, 
which result from misalignment and deletion, will also 
contribute to the OI phenotype. Because the exact structure 
of the protein product has not yet been identified, it is 
difficult to say specifically how these deletions affect its 
structure. 
Possible Gene Families and Protein Product 
The lack of "pure" triple helical coding sequence 
(Figure 13), along with similarity to collagen genes with 
exons larger than the 54 bp primordial unit, and a high 
similarity to sequences of the FACITs Types IX, XIV and XVI 
(Table 1) , all indicate that this gene may encode a non-
f ibrillar or fibril-associated {FACITs) molecule. 
Imperfections in the triplet pattern of non-f ibrillar 
collagens are often the result of a missing glycine so that 
the amino acid sequence is GLY-X-Y-X-Y. These sorts of 
imperfections are seen in many of the FACITs collagens 
{Gordon et al., 1991). Such imperfections afford the 
otherwise rigid protein more flexibility at that site. Also 
characterized by triplet sequence interruptions, the non-
collagenous {NC) domains of the FACITs often contain few, if 
any, glycine residues. The pattern in the Site 2 collagen 
gene is also an interrupted triplet sequence which contains 
a substitution for a glycine rather than a missing glycine so 
that the amino acid sequence (in some regions) is Gly-X-Y-Z-
X-Y (see Figure 13). This pattern also suggests that this 
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molecule has the potential for flexibility while still 
maintaining a collagen-like a-helical structure. 
The nucleotide similarity between NT735 and all three of 
the Type IX genes is in the region coding for the COL3 domain 
of the Type IX molecule {Table 1) . This region is adjacent to 
the "flexible hinge" which allows this domain and the 
globular NC4 domain to protrude into the perif ibrillar matrix 
{Figure 18). This flexibility imparts a unique, interactive 
capacity to the Type IX collagen molecule. The arrangement is 
ideal if the NC4 and GAG domains {see Figure 18) are to 
facilitate an interactive function with other cellular or 
extracellular matrix components. Although COL3 is collagenous 
in nature, it does not align in parallel with the Type I 
fibril. Thus, though a somewhat rigid extension is needed in 
order to project the NC4 domain into the matrix, a strict 
triple helix is less crucial, and perhaps in some cases 
impracticable, in this kind of region. The structure of the 
putative protein coded by p4.6 may serve a similar function, 
since it too has the potential flexibility of Type IX 
collagen, while maintaining a somewhat rigid form. 
Also adjacent to the COL3 domain of Type IX collagen, at 
the site of the hinge, is the GAG side chain attachment site 
{see Figure 18). This is the domain that imparts the 
proteoglycan characteristic and function to the otherwise 
collagenous nature of the Type IX molecule. It is this 
molecular architecture that makes the COL3 domain a bridge 
between the interactive components of the Type IX molecule. 
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It is possible that the same kind of region in p4.6 may serve 
a similar function. 
The NT735 translation (reverse frames) indicate other 
features in common with Type IX collagen and other FACITs, 
such as a high serine and leucine content and the abundance 
of cysteine residues (Ninomiya et al., 1990). Cysteine 
residues allow inter- and intra-molecular crosslinking of the 
collagen polypeptide and are important in determining the 
structure of the terminal globular domains of the Type IX 
molecules (Ninomiya et al., 1985). The abundance of these 
residues suggests that the p4.6 gene product has the capacity 
for forming other higher order structures in addition to a 
typical a-helix. 
In addition to its common features with the collagens 
and their genes, the high sequence identity of NT735 to the 
elastin-like wheat glutinen genes (Table 2), suggests the 
possibility that NT735 codes for an ECM gene which 
contributes tissue strength through an elastic type of 
flexibility. The sequence identity to human elastin (Table 2) 
supports this conclusion. The human elastin gene, like p4.6, 
contains high numbers of glycine and other hydrophobic 
residues as well as an abundance of Alu repetitive sequences 
(Indik et al, 1990). Two elastin exons with similarity to 
NT735 code for very hydrophobic regions of the molecule 
(Tatham et al., 1984). This agrees with codon frequency data 
indicating that NT735 codes a highly hydrophobic peptide. 
Amino acid sequence comparisons using the "Swissprot" 
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database indicate a nearly exclusive similarity of the NT735 
translation {reverse frames) with proteins containing 
hydrophobic transmembrane domains {Table 3). Much of this 
identity is with viral envelope glycoproteins and other 
transmembrane or cell/viral surface proteins. For example, 
there are long stretches of similarity to Hepatitis c virus 
envelope glycoprotein, Woodchuck hepatitis virus surface 
antigen, latent membrane protein of Epstein-Barr virus, and 
a shorter stretch of the Uukuniemi virus transmembrane 
portion of the G1 and G2 membrane glycoproteins. There are 
also multiple stretches of similarity to other transmembrane 
or membrane associated proteins such as the sodium channel of 
the rat heart {Cine), the cystic fibrosis transmembrane 
conductance regulator of ~ laevis, which has 77% identity to 
the human CF gene, and the surface exposed human Kell blood 
group glycoprotein. 
Most of these proteins are membrane-associated 
glycoproteins containing hydrophobic, a-helical transmembrane 
regions rich in the nonpolar amino acids Gly, Ala, Leu, Ilu, 
Val and Arg; the same features identified in the the putative 
peptide of NT735. Some are involved in membrane transport, 
for example, Na+ transport system and the CFTR channel 
activity {Rogart et al., 1989; Tucker et al., 1992). Others 
are viral envelope glycoproteins with effector functions 
(Moorthy et al., 1990, Kato et al., 1990; Kato et al., 1991), 
and yet others are transmembrane glycoproteins with a 
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structural and/or interactive role in matrix association 
(Ronnholm and Petterson, 1987). 
Many transmembrane glycoproteins are multidomain 
molecules also containing cytoplasmic and extracellular 
extensions with various functions (Nicholls, 1978). Other ECM 
associated receptor molecules have been described which 
contain such an architecture. For example, the ECM-associated 
membrane glycoproteins Syndecan and CD44 are ligand binding 
molecules which contain large interactive extracellular 
extensions anchored by an a-helical transmembrane domain 
which crosses the cell membrane multiple times (Sandell and 
Boyd, 1990). A short cytoplasmic domain may additionally 
associate intracellularly with the cytoskeleton. Both of 
these molecules are able to bind the intersitial collagens as 
well as other smaller ECM molecules (Jalkanen et al., 1991). 
The above 
similarity of 
sequence comparisons have identified high 
the NT735 sequence and its structural 
characteristics to a number of ECM components and 
transmembrane glycoproteins, which are important in directing 
the composition and structure of the extracellular matrix and 
effecting cellular interaction with the matrix (Alberts et 
al., 1989). This supports a function in which the putative 
protein encoded by the p4.6 locus could modulate the 
interaction of Type I collagen fibrils with the cell by 
acting as a communication bridge between them (Shaw and 
Olsen, 1991; Gordon et al., 1989). This is possible via a 
signaling function which directs the secretion of ECM 
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components or in a structural capacity, somehow connecting or 
associating the major fibril with other cell-secreted ECM 
components (Vaughan et al, 1988; Muller-Glauser et al., 
1986). 
If the p4.6 gene product does modulate Type I fibril 
interactions, then it has the potential to affect the 
strength and structural integrity of Type I collagen-
containing tissue. Thus, defects in p4.6 which disrupt this 
interactive capacity, could in turn effect the expression of 
the OI phenotype where either a Type I collagen defect is or 
is not present. For example, there are many cases described 
where substitutions for glycine in similar positions of the 
same polypeptide chain can produce drastic differences in 
severity between individuals. It is possible that a second 
mutation, which modulates the effect of a Type I collagen 
mutation, could cause a more severe condition, such as that 
seen in Type III OI. Alternatively, a single defect at this 
new collagen-like locus, could itself result in the Type III 
OI phenotype. 
RFLPs that are linked to the Type I procollagen genes 
have been shown to segregate with many of the autosomal 
dominant forms of OI (Sykes et al., 1990; Superti-Furga et 
al., 1989). However, the fact that multiple individuals 
carrying the same Type I collagen defect exhibit substantial 
variability in the severity of their OI clinical symptoms, 
even being asymptomatic, complicates diagnosis and genetic 
counseling. This situation can be greatly improved by the 
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detailed knowledge of other connective tissue genes, such as 
the p4.6 locus, that might modulate the OI phenotype. 
Sequencing of this "normal" p4. 6 allele provides the 
basis for examining the structure of deleted alleles in the 
normal population in comparison to those of asymptomatic 
parents and their affected offspring. This sequence 
information will permit pinpointing the specific deletion 
boundaries in OI patients which may suggest the molecular 
basis for the deletions. Ultimately, further characterization 
of this locus might permit its use as a marker for 
individuals predisposed to having a Type III OI child. 
Determining the detailed molecular organization of this 
\ 
locus has also been the necessary initial step in 
characterizing the structure, and ultimately the function, of 
the putative protein ( s) for which the new locus codes. 
Whatever its product, whether it be a true structural 
collagen, a related ECM protein, or a transmembrane 
glycoprotein with extracellular extensions that influences 
matrix assembly, this new locus is of importance since 
previous studies of OI patients and their families 
demonstrate that deletions at this locus are clearly 
associated with the disease. 
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